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Hydrogels differ from many other cell culture substrates in that they provide a three-di-
mensional, soft environment for cells, opposed to a two-dimensional surface on which 
cells are traditionally cultured. This geometry better represents the in vivo environment 
of cells. In addition, hydrogels are easily modified for enhanced cell viability and growth. 
Therefore, new hydrogels are continuously developed for cell culture and tissue engineer-
ing purposes.   
Applicability of a hydrogel as cell culture substrate depends on several chemical and 
physical attributes. Together these attributes affect cytocompatibility of the hydrogel, i.e. 
cell attachment, viability and cell specific response. The objective of this thesis was to 
create a protocol for first-step, short-term cell culture screening of new hydrogels. Cyto-
compatibility testing and analysis methods need to be adjusted for macroscopic 3D hy-
drogels compared to 2D culturing systems. Another challenge in this screening is ade-
quate stability of cells and their representativeness of the cells intended to be used in the 
final application.  
An interview was conducted with Regenerative Medicine professionals in BioMediTech 
Institute (University of Tampere) who are working with cardiomyocytes, bone and carti-
lage cells, corneal and retinal epithelial cells, and neuronal cells. Knowledge was gathered 
on the properties of representable cell models of each cell type and on tissue-specific 
aspects of analyzing. A commercial human embryonic fibroblast cell line WI-38 was cho-
sen as a representative first-step cell model and acquired for the first-step cytocompati-
bility testing. In addition, tissue specific cell lines were recommended for further testing. 
Cells were cultured ontop and encapsulated in PuraMatrix® and gellan gum hydrogels, 
and on poly(dimethylsiloxane) (PDMS) and uncoated well plate. Cells were stained with 
Live/dead viability/cytotoxicity kit. The suitability of Nikon BioStation CT cell culture 
observation system was evaluated for the screening of hydrogels and compared with two 
other imaging systems. It was possible to assess cell attachment and viability from fluo-
rescence images taken with BioStation CT, even though it was not an optimal imaging 
system for 3D hydrogel screening. As the result of this thesis, a first-step cytocompatibil-
ity testing protocol was created for assessing attachment and viability of cells that were 
cultured on top and encapsulated in hydrogels.  
   
 ii 
TIIVISTELMÄ 
 
JETTE-BRITT NAAMS: Nopea soluviljelyprotokolla materiaalien sytokombatibi-
liteettitestaukseen 
Tampereen teknillinen yliopisto 
Diplomityö, 76 sivua, 22 liitesivua 
Kesäkuu 2016 
Biotekniikan koulutusohjelma 
Pääaine: Kudosteknologia 
Tarkastajat: professori Minna Kellomäki, tohtorikoulutettava Janne Koivisto 
 
Avainsanat: sytotoksisuus, 3D soluviljely, hydrogeeli, gellaanikumi, biomateriaali, 
BioStation CT, fibroblasti 
Hydrogeelit eroavat monista muista soluviljelyalustoista niin, että ne tarjoavat soluille 
kolmiulotteisen, pehmeän kasvuympäristön. Perinteinen kasvualusta on sen sijaan kaksi-
ulotteinen ja kova pinta. Hydrogeelien kolmiulotteinen (3D) ympäristö kuvastaa parem-
min ympäristöä, jossa solut kasvavat kehossa. Lisäksi hydrogeelit ovat helposti kemialli-
sesti muokattavissa, jolloin solujen kasvua ja elinkykyisyyttä materiaalissa voidaan pa-
rantaa. Uusia hydrogeelejä kehitetäänkin jatkuvasti soluviljelyn ja kudosteknologian tar-
peisiin. 
Hydrogeelin soveltuvuus soluviljelyn kasvualustaksi on riippuvainen monista sen kemi-
allisista ja fysikaalisista ominaisuuksista. Nämä ominaisuudet vaikuttavat yhdessä hyd-
rogeelin sytokompatibiliteettiin, eli solujen kiinnittymiseen, elinkykyisyyteen ja solutyy-
pistä riippuvaan vasteeseen. Tämän diplomityön tarkoituksena oli kehittää lyhytaikaiseen 
soluviljelyyn perustuva protokolla uusien hydrogeelien alkuvaiheen seulontaan. Koe- ja 
analysointimenetelmiä on säädettävä sytokompatibiliteetin testaamiseksi, kun soluja kas-
vatetaan 3D-materiaalissa verrattuna kaksiulotteisella materiaalilla kasvattamiseen. Li-
säksi seulonnan haasteena on solujen riittävä stabiilius sekä edustavuus verrattuna solui-
hin, joita on tarkoitus käyttää lopullisessa sovelluksessa. 
Diplomityössä haastateltiin BioMediTech -instituutin (Tampereen yliopisto) Regeneratii-
visen lääketieteen tutkimusryhmiä, jotka tutkivat kardiomyosyyttejä, luu- ja rustosoluja, 
verkkokalvon ja sarveiskalvon soluja sekä hermoston soluja. Haastattelussa kerättiin tie-
toa kutakin solutyyppiä edustavien solujen ominaisuuksista sekä näiden solutyyppien 
analysoimisesta. Kaupallinen ihmisen embryonaalinen fibroblastisolulinja WI-38 valit-
tiin edustavaksi ensimmäisen vaiheen solumalliksi ja se hankittiin ensimmäisen vaiheen 
sytokompatibiliteettitestausta varten. Lisäksi jatkotutkimuksia varten ehdotettiin kudos-
kohtaisia solulinjoja. 
Soluja kasvatettiin PuraMatrix®- ja gellaanikumihydrogeelien päällä ja sisällä, sekä po-
lydimetyylisiloksaanilla (PDMS) ja päällystämättömällä kuoppalevyllä. Solut värjättiin 
Live/dead viabiliteetti/sytotoksisuus -kitillä. Nikon BioStation CT -kuvantamisjärjestel-
män soveltuvuutta hydrogeelien seulontaan arvioitiin, ja sitä verrattiin kahteen muuhun 
kuvantamisjärjestelmään. BioStation CT:n avulla saaduista fluoresenssikuvista oli mah-
dollista määrittää solujen elinkykyisyys ja kiinnittyminen, mutta se ei kuitenkaan ollut 
optimaalinen 3D-hydrogeelien seulontaan. Diplomityön tuloksena tuotettiin sytokompa-
tibiliteetin testausprotokolla, jota voidaan käyttää hydrogeelien päällä ja sisällä kasvatet-
tujen solujen kiinnittymisen ja elinkykyisyyden määrittämiseksi.   
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TERMS AND DEFINITIONS  
 
Aneuploidy  Having a chromosome number that is not an exact multiple 
of the haploid number, caused by one chromosome set being 
incomplete; not euploid  
ARPE-19 Commercial retinal pigment epithelial cell line 
BrdU 5-bromo-2´-deoxyuridine 
Biocompatibility The ability of a foreign material to fulfil its intended function 
with an appropriate host organism response  
Ca-AM Calcein-AM, calcein acetoxymethyl 
CCD-1112Sk Commercial human foreskin fibroblast cell line 
Confluence Approximate proportion of the cell culture surface covered 
by cells in monolayer  
CE Corneal epithelium 
CNS Central nervous system 
DAPI 4,6-diamidino-2-phenylindole 
Dil 1'-dioctadecyl-3,3,3',3'-tetramethylindocarbocyanine per-
chlorate 
Diploid Containing two complete sets of chromosomes, one from 
each parent 
DPBS Dulbecco's Phosphate-Buffered Saline; a commercial saline 
solution 
ECM Extracellular matrix 
EFR Effective focus range 
ELISA  Enzyme-linked immunosorbent assay 
END2 Clonal cell line from mouse embryonal carcinoma 
EthD-1 Ethidium homodimer-1 
FAK Focal adhesion kinase 
FBS Fetal bovine serum 
GG Gellan gum 
Haploid Having a single set of unpaired chromosomes 
Hydrogel A three dimensional network of polymer chains that retains 
water within the spaces between the macromolecules  
Immortalization  Acquisition of infinite life span of a cell line 
HCE-T Commercial corneal epithelial cell line 
hESC Human embryonic stem cell 
hFF Human foreskin fibroblast 
hNP1 Commercial human neural progenitor cell line 
hTERT (Human) telomerase reverse transcriptase; subunit of the en-
zyme telomerase  
iCell® Neurons Commercial human cerebral cortical neurons 
iPS cell Induced pluripotent stem cell 
 vii 
Ki-67  Nuclear protein associated with cell proliferation and riboso-
mal RNA transcription 
L929 NCTC clone 929 (commonly known as L929 or L-929), 
commercial fibroblast cell strain  
MRC-5 Commercial human fetal fibroblast cell line 
MSC Mesenchymal stem cell 
MTS  3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-
2-(4-sulphophenyl)-2H-tetrazolium 
MTT  3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bro-
mide 
PA6  Commercial cell line from mouse bone marrow, also named 
MC3T3-G2/PA6 
PEG Poly(ethylene glycol) 
PEO Poly(ethylene oxide) 
PM PuraMatrix® Peptide Hydrogel 
Proliferation The process whereby cells reproduce themselves by growing 
and then dividing into two equal copies 
PDL Population doubling level of cells 
PVA Poly(vinyl alcohol) 
RPE Retinal pigment epithelium 
SAOS-2 Commercial osteosarcoma cell line 
SH-SY5Y Commercial human neuroblastoma cell line 
Senescence The phenomenon leading to cell death due to its age  
SPD Spermidine; N-(3-aminopropyl)-1,4-diaminobutane 
Telomeres Terminal regions of the chromosomes, which maintain the 
proliferative capacity of cells and are progressively short-
ened during cell division 
WI-38 Commercial human embryonal fibroblast cell line  
WSTs  Water Soluble Tetrazolium Salts 
XTT  2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-
5-carboxanilide  
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1. INTRODUCTION 
Over the past decades, interest in hydrogels has grown in biomedical research due to their 
soft and tissue-like physical properties, hydrophilicity, possibility to fabricate from bio-
compatible and biodegradable polymers, and ease of further functionalization [1], [2]. 
Hydrogels are hydrophilic polymer networks that retain water within the spaces between 
the macromolecules. They are able to absorb from 10-20 % up to thousands of times their 
dry weight in water without losing their structural integrity. [1], [3] Hydrogels have been 
used in many biomedical applications, such as drug delivery systems, cell encapsulation, 
wound dressings and contact lenses. In tissue engineering they have been used as cell 
culture environments and tissue engineering scaffolds. [2], [3] 
 
In the body, cells are surrounded by extracellular matrix (ECM), which they produce and 
secrete. The ECM serves as a support to the tissue, and cells have complex interactions 
with the ECM and adjacent cells. [4], [5] In a cell culture in vitro, the culture substrate 
takes the role of the ECM and should mimic the properties of natural ECM. Hydrogels 
differ from many other cell culture substrates in that they provide a three-dimensional 
(3D) environment to cells, opposed to a two-dimensional (2D) surface on which cells are 
traditionally cultured. On a surface, cells grow mostly in a monolayer along the surface, 
and the 2D geometry changes the interactions between cells and between surrounding 
matrix and cells. This constitutes many of the differences in cell behavior seen in vitro 
compared to the behavior in vivo. For this reason, cell culture substrates such as hydrogels 
have been prepared to allow cells to migrate and re-aggregate into more natural 3D struc-
tures. [6, p. 3-9] 
 
A variety of synthetic and natural polymers as well as cross-linking agents and fabrication 
methods can be used to manufacture hydrogels, and also a variety of modifications can 
be made to the polymers. The applicability of a hydrogel for tissue engineering applica-
tions depends on several factors, such as mechanical, kinetical, biological and mass 
transport properties. [3] New hydrogels are constantly developed to provide better phys-
ical or biological properties for different applications. These new hydrogels have to be 
tested for the above mentioned properties as well as the toxicity and biocompatibility of 
the raw material itself. One way to test cell reaction with a new hydrogel is to culture cells 
on top or encapsulated in the new hydrogel in vitro.  
 
To select the best ones among all possible hydrogels, there is a need for fast and simple 
cytocompatibility screening process. Currently, there is no widely used or standardized 
protocol for such high-throughput screening of hydrogels with cells [3]. One of the chal-
lenges in the screening process is the stability of cells: when growing cells on hydrogels, 
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there is often biological variation in cell behavior [7], thereby making it difficult to de-
termine if the observed difference is a result of an unfavorable hydrogel or only due to 
the varying biological factors. In addition, some analysis methods need adjustment when 
cells are cultured in 3D hydrogels compared the traditional 2D culturing systems [8], [9]. 
 
The objective of this thesis is to create a protocol for repeatable, short-term cell culture 
screening of cytocompatibility of new hydrogels. The results from this screening should 
be applicable to culturing of cardiomyocytes, bone and cartilage cells, and corneal, reti-
nal, and neuronal cells. More specifically, this thesis has two aims. The first aim is to find 
cell lines and their culturing techniques resulting in minimal biological variation in their 
attachment, proliferation, viability, and cell type specific thriving when grown on hydro-
gels that are cytocompatible. The cell lines should be, however, sensitive enough to show 
variation in these results due to adverse change in culturing conditions such as unfavora-
ble hydrogel. The second aim is to select appropriate analyzing methods that would easily 
reveal the cytocompatibility of chosen hydrogels.  
 
This protocol is meant to be used in future studies as a fast and simple, first step in vitro 
test, where new hydrogels are studied as possible cell culture or tissue engineering mate-
rials. The protocol can also be applied when investigating other factors affecting cell 
growth, such as coatings, fibers, fluid flow in bioreactor or molecules incorporated to the 
hydrogel (or other materials) and in the growth medium. 
 
 
 3 
THEORETICAL BACKGROUND 
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2. CYTOTOXICITY AND BIOCOMPATIBILITY 
TESTS OF MATERIALS 
Hydrogels that are designed to be used as cell culture substrates are formed from poly-
meric biomaterials. Polymeric biomaterials are studied for, or are already in use, as med-
ical devices or as parts of medical devices. A biomaterial is a material that is exploited in 
contact with living tissues, organisms, or microorganisms. The exploitation can include 
usage both in applications and for fundamental research. [10]  
 
There are several biological hazards that are involved when materials come to contact 
with cells or tissues. [11] This chapter introduces terminology related to safety of bio-
materials and key standards for testing biological hazards, especially cytotoxicity.  
2.1 Definitions 
According to International Union of Pure and Applied Chemistry (IUPAC), the term bi-
ocompatibility is used to refer to the ability (of a material, for example) to be in contact 
with a living system without producing an adverse effect [10]. There are, however, several 
slightly different definitions for biocompatibility. Perhaps the most known definition was 
given in Williams Dictionary of Biomaterials in 1987, which states that “biocompatibility 
refers to the ability of a material to perform with an appropriate host response in a specific 
situation” [12 In: 13]. This definition does not only state that the material has to be safe 
(causes no biological hazards) but also that it has to be able to perform in the function 
given to it in the specific application. Thus, biocompatibility is a rather broad term. The 
same definition is accepted by IUPAC when referred to polymers of biological and bio-
medical interest [10]. 
 
Toxicity, in contrast, is the “consequence of adverse effects caused by a substance on a 
living system”, as defined by IUPAC [10]. When the living system is specifically cells, 
term cytotoxicity is used. Toxicity can be acute or chronic, depending on the time period 
needed for the reactions to occur. Several factors affect the nature and degree of the ad-
verse effects and they can be quantified by the observed physiological response or by a 
viability test. [10] The physiological response may be, for example, change in prolifera-
tion rate, morphology or attachment of the cells. [14, p. 9] 
 
Often biocompatibility of a material in vitro is only assessed by testing cytotoxicity (such 
as in [15]). In this thesis, however, the purpose of the screening is to ultimately select 
materials that surpass their control materials as a cell culture substrate. Therefore, a more 
specific term, cytocompatibility, is used here to describe a material that is not cytotoxic 
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and is able to fulfill its intended function with an appropriate cellular response. The in-
tended function in this case is to act as a cell culture substrate, which supports normal cell 
behavior. In more detail, this means that the material does not cause significant cell death 
or decrease in proliferation rate, and the material enables cells to grow in their normal 
morphology. Other cell specific responses may also be tested to ensure normal behavior 
of cells. 
 
It must be noted that also the definitions of positive and negative controls are opposite 
depending on whether cytotoxicity or cytocompatibility is tested. When testing cytotoxi-
city (in accordance with ISO 10933-5), a positive control is the material that causes a 
reproducible cytotoxic response in cells and a negative control is the material that does 
not cause a cytotoxic response [14]. On the contrary, when testing cytocompatibility, such 
as in this thesis, a positive control is a material that supports cell growth or other desired 
cellular functions and does not cause a cytotoxic response; a negative control is a material 
that does not support cell growth or other desired cellular functions or causes a cytotoxic 
response. Optimally, controls should be selected so that they can be prepared by the same 
procedure as the test sample [14]. 
2.2 Standards for testing cytotoxicity and biocompatibility 
The International Organization for Standardization (ISO) describes in vitro cytotoxicity 
testing of medical devices in Part 5 of standard 10993 “Biological evaluation of medical 
devices”. [14] Testing of cell culture substrates can be conducted following this standard, 
because the cell substrate material can be classified as a medical device according to ISO 
10993-1; it fulfills the criteria of a material intended by the manufacturer to be used alone, 
or in combination, for human beings for the purpose of providing information for medical 
purposes by means of in vitro examination of specimens derived from the human body. 
[11] 
 
Standard ISO 10993-5 describes the general principles and decisions to be made when 
conducting an in vitro cytotoxicity study. In general, cytotoxicity is tested by imposing 
cells to the test material or its extracts. After an exposure time, cytotoxic effects are eval-
uated. This can be done by assessing cell damage as indicated by cell morphology, or by 
measuring cell damage, cell growth or specific aspects of cellular metabolism. [14] 
 
There are three main categories of cytotoxicity tests: extract test, direct contact test, and 
indirect contact test. The category that is chosen for testing depends on the device that is 
tested and the intended nature and site of use of the device. Direct contact test can be used 
to test materials with many shapes, sizes and physical states, including solids, liquids and 
gels, and the materials can be tested as such without any modifications. The direct contact 
cytotoxicity test is conducted by placing a test sample of a previously cultured, subcon-
fluent cell layer in a culture vessel. The sample should cover a ratio, such as 1/10, of the 
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cell layer surface. However, with appropriate specimens, the specimen can be placed in 
the vessel first and cell suspension can be then pipetted on the sample. The samples are 
incubated in normal cell culture environment over a period of time, which depends on the 
following assay. [14]  
 
The purpose of extract test is to assess cytotoxic effects of substances that might extract 
from the test material or device in clinical conditions (i.e. leachables). To obtain the ex-
tract, the sample is incubated in 37 °C or heightened temperature over 1 to 72 hours in 
cell culture medium or other solute. Cells are then exposed to the extract. Indirect contact 
tests, namely agar diffusion and filter diffusion tests, also assess cytotoxicity of leachables 
from the sample material. In indirect contact tests, an agar gel or a porous filter is sepa-
rating cells from the sample. Agar diffusion test is only suitable for leachables that can 
diffuse through agar and which do not react with agar. According to ISO 10993-5, using 
agar diffusion test for cytotoxicity testing must be justified. After an incubation period, 
samples are removed and cytotoxic effects to cells are assessed (by an appropriate stain-
ing method). [14] 
 
In this thesis, the aim is to culture cells directly on top or encapsulated inside hydrogels. 
This sample setup is closest to the direct contact testing. Therefore, the protocol presented 
in this thesis relies on similar principles than in direct contact test presented in ISO 10933-
5 [14], especially when testing cell behavior on top of hydrogels.  
 
Both indirect contact tests allow only qualitative assessment of cytotoxicity, whereas ex-
tract test and direct contact test allow qualitative and quantitative assessment of cytotox-
icity. Quantitative assessment is preferred, but qualitative assessment can be useful espe-
cially for screening purposes. [14] In general, qualitative assessing occurs by evaluating 
morphological aspects of cells microscopically (after cytochemical staining if appropri-
ate). These morphological aspects may include general morphology, such as shape and 
size, vacuolization, detachment, cell lysis, or cell membrane integrity. A change from 
normal morphology is graded descriptively or numerically. In extract test, the condition 
in the whole cell layer is observed, whereas in indirect and direct tests the size of a reac-
tivity zone around and under the sample area can be evaluated, if the sample only covered 
a part of the cell layer. [14] 
 
Quantitative assessing occurs by measuring a parameter indicating cell death, inhibition 
of cell growth, cell proliferation (the process whereby cells reproduce themselves by 
growing and then dividing into two equal copies), or colony formation. This measurable 
parameter may be, for example, the number of cells, amount of a certain protein, release 
of enzymes, release of vital dye, or reduction of vital dye. In general, 30% reduction in 
cell viability is considered a cytotoxic effect. Other evaluation criteria must be determined 
and described, based on the application. [14] 
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The standard ISO 10993-5 leaves open the specific test method (assay or staining method) 
by which cytotoxicity has to be assessed. Therefore, the standard remains applicable to 
many types of devices and allows new methods to be used. Nonetheless, some example 
methods were given for extract test, such as XTT ((2,3-bis-(2-methoxy-4-nitro-5-sul-
fophenyl)-2H-tetrazolium-5-carboxanilide) assay and MTT (3-(4,5-dimethylthiazol-2-
yl)-2,5-diphenyltetrazolium bromide) assay. These and other commonly used assays for 
determining cytotoxicity and cytocompatibility are described in Chapter 6. 
 
Cytotoxicity testing is one part of assessing biological effects of a medical device. De-
pending on the device, its nature of body contact and contact duration (limited, prolonged, 
permanent), additional tests may be needed along with cytotoxicity testing. These tests 
include assessing some or all of the following biological effects [11]: 
 sensitization 
 irritation or intracutaneous reactivity 
 systemic toxicity (acute) 
 subchronic toxicity (subacute toxicity)  
 genotoxicity  
 implantation 
 haemocompatibility 
 chronic toxicity 
 carcinogenicity  
 biodegradation  
 toxicokinetics 
 immunotoxicity and 
 reproductive / developmental toxicity or other organ-specific toxicities. 
 
The current protocol focuses on testing cytotoxic effects of material on mammalian cells 
in vitro. Should the material be considered as a candidate for in vivo use (or bringing it 
into contact with human or animal tissue), a full risk assessment according to ISO 10993-
1 should be done, and the biological hazards mentioned above should be evaluated and 
tested for, if necessary. Standards for testing these affects are found in respective parts of 
ISO 10993. In addition, several methods for assessing cytotoxicity may be needed. [11] 
2.3 Standards for testing hydrogel compatibility for cell cul-
ture 
In addition to considering cytotoxicity of the raw materials that hydrogels are comprised 
of (polymers and crosslinkers), other factors have to be taken into account for character-
izing suitability of hydrogels in regenerative medicine. Many properties of hydrogels ul-
timately affect their applicability to act as cell culture substrates: permeation of dissolved 
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gases, nutrients and biomolecules; ability to sustain cell growth and migration; degrada-
tion; release of drugs and/or biologics at an appropriate rate; and ability to maintain their 
shape [3].  
 
The key factors that affect the suitability of hydrogels for regenerative medicine use, and 
attributes that are related to these factors are presented in Table 2.1. Many of the attributes 
presented in this table are interconnected with each other. For example, environmental 
stability is assessed by testing different properties such as swelling, mechanical proper-
ties, gelling time, and ability to encapsulate cells in response to different environmental 
conditions. [3] 
 
Table 2.1 Key factors and attributes to be considered in hydrogel characterization (mod-
ified from [3]). For further information on each attribute, refer to listed ISO and ASTM 
standards.  
Key factors Attribute Standards 
Biological properties 
Biocompatibility ISO 10993, F748, F895 
Adventitious agents  
F2383, ST72, ISO 22442,  
21 CFR 210, 21 CFR 221,  
21 CFR 610, 21 CFR 820 
Kinetics 
Gelling time F2315 
Swelling rate ISO 10993, F2214 
Matrix degradation  F2150 
Physical and chemical 
stability 
Environmental stability D4516 
Mechanical properties F2150 
Cell encapsulation F2315 
Mass transport 
Cell migration F2315 
Transport of nutrients and waste F2450 
Release rate of bioactive agents F2450 
 
Cell response towards a hydrogel can be assessed by testing biocompatibility and cell 
migration. It must be noted, however, that all attributes presented in Table 2.1 ultimately 
affect also response of cells. For example, transport of nutrients and waste products is 
essential for the cells to survive and function inside a hydrogel. Likewise, both biochem-
ical and physical properties of the cell environment affect cell function and tissue mor-
phogenesis. Therefore, also attributes such as mechanical properties and environmental 
stability impact the ability of hydrogels to support cells in their attachment, migration, 
differentiation, and other functions. Different tissues have distinct mechanical properties 
(e.g. stiffness), hence, optimally hydrogels for tissue-engineered constructs would be de-
signed to roughly correlate with these mechanical properties. [2], [16] 
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3. MAMMALIAN CELL CULTURE AND REPEATA-
BILITY 
A cell culture refers to growing cells in vitro, i.e. in an artificial environment suitable for 
the cell in question. Cell culturing was first established as a method for studying cells in 
a controlled manner. Unlike in vivo, physiological and physical conditions can be kept 
constant in a cell culture, without systemic variations affecting the cells, such as changes 
in hormone levels in the organism. [6, pp. 1–6], [17] In addition, cells and their behavior 
in a culture can often be analyzed more easily than in vivo, for example by observing with 
a microscope (and immunostaining) or by electrophysiological measurements. However, 
cell culture has its limitations, which stem from various differences in in vivo and in vitro 
conditions. The major differences are that in vitro cells are detached from the 3D geom-
etry surrounding them in vivo and that cells lack interactions with their natural ECM and 
adjacent heterotypic cells. Nevertheless, if these limitations are kept in mind, cell cultures 
are very useful models for studying cells. [6, pp. 1–31] 
 
Nowadays, cell culturing is used for various research and production purposes. It is an 
excellent method for studying cellular and molecular biology: intracellular activity, ge-
nomics, cell products, and cell-cell interactions, for example. It also enables research on 
cell-matrix interactions, which is a fundamental concern in tissue engineering. In addi-
tion, cell culture is a useful model for immunological, toxicological, and pharmacological 
studies. Beyond this, cell culturing can be used for large scale manufacturing of biologi-
cals such as vaccines and hormones; however, cell cultures for production are out of the 
scope of the protocol developed in this thesis. [6, p. 4], [17], [18]  
3.1 Culture types 
The general term of tissue culture refers to both cell culture and organ culture. Organ 
culture means culturing of a three-dimensional, undisaggregated tissue, which retains 
some or all of the histological features it possessed in vivo. Cell culture, on the other hand, 
refers to culture of disaggregated cells. A cell culture can be initiated from cells dispersed 
from the original tissue, from a primary culture, or from already existing cell line or cell 
strain.  [6, p. 3], [19, p. 862]  
 
Cells are traditionally cultured on a two-dimensional plastic or glass surface. However, 
there are histotypic cultures, in which cells are re-aggregated or grown to re-create a three-
dimensional structure with tissue-like cell density. This can be achieved, for example, 
with the help of a three-dimensional matrix, such as collagen gel. Furthermore, an organ 
culture must not be confused with an organotypic culture. In an organotypic culture, a 
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tissue equivalent is attempted to achieve by combining cells from different lineages in the 
culture. [6, p. 3]  
3.1.1 Primary cell, cell line and cell strain 
A primary culture is established either by allowing outgrowth of cells from a tissue ex-
plant, or by enzymatically or mechanically dispersing tissue and culturing the subsequent 
cell suspension [6, p. 39], [19, p. 865]. Cells in this culture are called primary cells. Cells 
proliferate in or on their culture substrate, until they have used all the available space, i.e. 
reached confluence [6, p. 40]. In order to maintain healthy growth of the cells, the culture 
must be subcultured (i.e. passaged) before reaching confluence [19, p. 865]. This involves 
enzymatic disaggregation, dilution, transfer to a new culture vessel and adding fresh cul-
ture media. After the first subculture, the culture is known as a secondary culture, and at 
the same time, starts a new cell line. The cell line can be further propagated and subcul-
tured several times. [6, p. 41], [17], [19, p. 862]  
 
A cell strain or subline, on the other hand, is formed by selecting cells from a culture by 
cloning or other means [17]. The resulting cell population in one culture flask is, thus, 
derived from a single cell. The purpose of forming cell strains is to obtain genetically 
homogenous cultures. [19, p. 866] A cell strain has certain characteristics and a sustained 
marker is required to recognize these characteristics. The cell strain can also be finite or 
continuous (see Chapter 3.1.3), depending on how it was derived. [20, p. 31]. However, 
cell strains often acquire genetic changes after the selection, distinguishing the cells from 
the parent cell line [17]. Thousands of cell lines and cell strains are nowadays in regular 
use in research and commercially available through several cell repositories [19, pp. 866–
867], [21]–[24].  
 
3.1.2 Formation of cell line 
Formation of a cell line from a primary culture consists of a selective process. With each 
passage, cells or cell lines which have the highest growth capacity will become more 
predominant, and “weaker” cells will dilute out. The growth capacity of the cells is influ-
enced by attributes such as proliferation rate, ability to adhere to the substrate, and ability 
to grow under the chosen culture conditions. Equally, cells have varying abilities to with-
stand the enzymatic handling during passage. These selective circumstances lead to a 
certain level of genotypic and phenotypic uniformity in the cell population. By the third 
passage, the cell line can be assumed to be rather stable and to consist mainly of a hardy, 
rapidly proliferating cell. The cell line can be characterized, and these characteristics will 
apply for the most of the life span of this finite cell line. [6, pp. 9, 41], [17], [19, p. 865] 
 
The predominance of these hardy cells is problematic, if a cell line is wished to be formed 
from a more fragile cell, or a cell with lower proliferation rate. In addition, in the past 
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decades, phenotypic loss of characteristics was noticed in cell lines, which was interpreted 
as dedifferentiation. Nowadays it is understood that this phenomenon, too, is in fact over-
growth of undifferentiated cells of the same or different lineage. For that reason, several 
selective media and substrates have been developed, that allow isolating these more frag-
ile cell lineages and maintaining or restoring many of the specialized characteristics of 
the cells. [6, pp. 7, 41], [25, p. 318] 
3.1.3 Finite and continuous cell lines 
Cell lines can be either finite or continuous. Cell lines derived from normal tissue (e.g. 
not tumors) are finite. Finite cell lines can be subcultured and maintained for a limited 
number of population doublings before the cells cease to proliferate and die due to senes-
cence. [6, p. 41], [17], [19, p. 862] Senescence is a natural phenomenon, which occurs at 
least partly due to the incapability of the cell to replicate the terminal sequences of DNA 
in the telomeres during cell division [6, p. 41]. 
 
Another possible fate of the cell line, instead of senescence, is becoming immortal 
through a process called transformation. When a cell line becomes immortal, i.e. it can 
divide indefinitely, the cell line is said to be a continuous (or as previously called, estab-
lished) cell line. The transformation giving rise to continuous cell lines can occur sponta-
neously or it can be chemically or virally induced. [6, pp. 9, 41], [17], [19, pp. 882, 866] 
Transformation can also occur after exposure to ionizing radiation or chemical carcino-
gens [6, p. 291].  
 
It must be noted, that the term transformation is used differently in different sources and 
fields. Freshney [6] uses the term immortalization to describe acquisition of infinite life 
span, and the term transformation implying to three phenotypic changes: immortalization, 
alterations in growth characteristics and malignancy (growth of invasive tumors in vivo). 
A cell line can go through one or more of these three phenotypic changes during trans-
formation. The alterations in growth characteristics may be loss of anchorage dependence, 
loss of contact inhibition and loss of density limitation of growth (see Chapter 3.3), and 
these alterations often, but not necessary correlate with tumorigenicity. It is possible, 
however, to achieve immortalization, without aberrant alterations in growth control and 
malignancy. [6, pp. 41, 291]  In addition, when untransformed cells become continuous, 
cell lines often loose differentiated properties of the phenotype. [6, p. 375] 
 
Some cell types are capable of giving rise to continuous cell lines. Cells that are more 
prone to genetic change, i.e. are genetically instable, are more likely to transform. Nor-
mal, finite human cells are genetically quite stable. For example, human fibroblasts re-
main predominantly euploid (having a chromosome number that is an exact multiple of 
the number of single (haploid) set of unpaired chromosomes) throughout their lifespan in 
culture and never give rise to continuous cell line. [26 In: 6] Fibroblasts from other spe-
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cies, especially mouse, are genetically unstable and, thus, transform easily. Genetic insta-
bility is a common feature of continuous cell lines, especially those derived from tumors, 
still after the transformation. Continuous cell lines are usually aneuploid (i.e. have a chro-
mosome number that is not an exact multiple of the haploid number) and have chromo-
some number between diploid and tetraploid values.  In addition, the chromosome num-
ber may vary among the cell population, i.e. there is heteroploidy. [6, pp. 41, 291–292] 
 
In addition to transformed cells, germ cells and stem cells have extended life spans com-
pared to normal finite cells. Life span of germ cells and some tumor cells is indefinite. 
These cells often express telomerase, an enzyme which gives them the capability of rep-
licating the terminal sequences of telomeres. [6, p. 41] 
3.1.4 Stem cells 
Stem cells are cells that have the ability both for self-renewal (making identical copies of 
themselves) and for differentiation. For in vitro research, specialized cells are often dif-
ferentiated from embryonic stem cells (ESC), induced pluripotent stem cells (iPS) or adult 
stem cells. ESCs and iPS cells are pluripotent, i.e., they are able to differentiate into cells 
of any of the three germ layers (but not form an entire new organism). Both embryonic 
and iPS cells can be differentiated into several cell lineages and cell types in vitro, for 
example, neuronal precursor cells, glial cells and neurons. [27]–[29]  
 
Embryonic stem cells are obtained from the inner cell mass of a blastocyst. Both mouse 
and human ESCs have been used extensively in research. Human ESCs are obtained from 
embryos that are left over from artificial insemination. Several embryonic stem cell lines 
are also available commercially. [28] iPS cells have been reprogrammed into stem cells 
from adult differentiated cells, such as fibroblasts, and are similar to embryonic stem cells 
in properties. [27]  
 
In addition to embryos and fetuses, stem cells are present in many adult tissues. Most of 
these adult stem cells (also called organ- or tissue-specific stem cells or somatic stem 
cells) are multipotent, meaning that they have the ability to give rise to limited cell types. 
[28] For example, bone marrow contains two types of adult stem cells: haematopoietic 
stem cells and bone marrow stromal cells [30, p. 17]. It is possible to harvest adult stem 
cells in connection with surgeries, but some adult stem cells, like mesenchymal stem cells, 
are also available commercially. [30, p. 18] 
 
The difficulty in differentiating pluripotent and multipotent stem cells is in obtaining uni-
form populations of cells. Differentiation can be induced in several ways: by changing 
the constitution of culture media, with added growth factors, cytokines or other proteins; 
by changing the substrate, for example into a 3D matrix, and utilizing mechanotransduc-
tion of the cell; or by co-culture with cells that already have differentiated phenotype. [30, 
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p. 6] Another challenge with stem cells is that cells from one patient might behave differ-
ently than cells from another patient. Therefore, cells have to be harvested from multiple 
patients for a single experiment, in order to obtain validated results. [30, p. 18] 
 
Different types of stem cells offer a great potential in tissue engineering and are exten-
sively studied. Therefore, hydrogels are also studied as possible in vitro substrates for 
stem cells and precursor cells, either serving as differentiating substrate or a substrate that 
remains cells in undifferentiated state. Even though ultimately a goal in hydrogel research 
is to provide suitable hydrogel candidates as 3D matrices for stem cells, this protocol does 
not extend to testing differentiation of stem cells.    
3.2 Advantages and disadvantages of cell lines 
The source of cells for a cell line determines the composition of cells in the population. 
When the source is an embryo, more stem cells and precursor cells are present than when 
the source is adult tissue, and thus the cells have greater self-renewal capacity. Further-
more, cells from adult tissues that have a good self-renewal capacity in vivo, such as in-
testinal epithelium and epidermis, contain some amount of stem cells. Thus cultures de-
rived from these tissues, given the appropriate environment, will also have a longer life 
span in vitro than cells derived from tissues with slow renewal rate (or which renew only 
under stress). The latter rely their self-renewal ability only on precursor cells, which have 
a limited life span. [6, p. 42] 
 
The selection process that occurs during formation of cell lines produces advantages and 
disadvantages of cell lines. The uniform constitution of cell lines offers a great advantage 
of repeatability for experiments, as at each subculture, replicate samples are identical to 
each other [6, p. 6]. Cell lines are also a renewable source of cells for repeated experi-
ments [19, p. 866], unlike primary cells, which have to be isolated from animals or hu-
mans for each experiment. Furthermore, primary cultures are less stable than cell lines, 
and therefore unsuitable for some studies [6, p. 39].  
On the other hand, the loss of heterogeneity and diversity of the culture in cell lines makes 
them less representable of the tissue of origin. Ideally, the cell line should reflect the 
properties of tissue from which they were derived. [19, pp. 865–866] However, primary 
cultures express more strongly some aspects of specialized functions, which are apparent 
in vivo [6, p. 40]. Therefore, a cell line should be considered merely as a model of its 
tissue of origin.  
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3.3 Growth characteristics  
Cells can be cultured either in an adherent culture or in a suspension culture. In adherent 
cultures, cells attach to a solid or semi-solid substrate and propagate as a monolayer. This 
means that given the opportunity, cells will propagate on the two-dimensional surface, on 
which cells are traditionally cultured. Adherent cells are anchorage dependent, meaning 
that attachment to, and to some extent spreading onto, the substrate is a prerequisite for 
proliferation. Most normal cells, with the exception of haematopoietic cells, are anchor-
age dependent. Cells from malignant tumors and some transformed cell lines, on the other 
hand, are anchorage independent. They do not attach to a substrate; instead they are cul-
tured in a suspension within the growth medium. [6, p. 9], [17], [19, p. 862]  
 
Different types of cells have different levels of contact inhibition, which means stopping 
migration when cells are in confluence, together with a reduction of plasma membrane 
ruffling. Based on their morphology, adherent cells are described either as fibroblast-like 
or epithelial-like, but they also have different growth characteristics. Fibroblast-like cells 
require mainly attachment and spreading on the surface for their migration and prolifera-
tion. At low densities, they migrate as single cells with distinctive polarity in the move-
ment. When encountering another cell, polarity reverses. In confluence, directional move-
ment ceases and eventually cells withdraw from the division cycle. In contrast, epithelial-
like cells may require also adhesion with other cells in order to survive and grow opti-
mally. Unless transformed, epithelial-like cells in low densities migrate until they encoun-
ter another cell. This leads to the cells growing in patches and even the whole patch can 
show coordinated movement. [6, pp. 31, 34]    
 
Cells in monolayer culture proceed to proliferate and migrate until all the available growth 
area on the surface has been occupied, i.e. the culture is confluent. After reaching conflu-
ence, both epithelial-like and fibroblast-like cells may differentiate, depending on their 
environment. In addition, epithelial cells may form increasing amount of desmosomes 
and complete junctional complexes, if they are left at confluence for too long. This makes 
disaggregating cells difficult. Cells that are sensitive to contact inhibition and density 
limitation of cell proliferation stop diving at confluence, but transformed cells that have 
lost sensitivity to density limitation will overgrow. Therefore, frequent subculturing be-
fore reaching confluence is necessary in order to keep the phenotype of the culture nor-
mal, especially in cultures which easily transform (such as mouse fibroblasts). [6, pp. 33, 
40], [17], [19, p. 865]   
 
Passage number indicates the number of times a cell culture has been subcultured. For 
diploid cells, passage number is roughly the same as number of population doublings 
since the culture was started, i.e. population doubling level (PDL). Continuous cell lines 
are subcultured in a higher split ratio (i.e. into higher amount of new vessels) and therefore 
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their passage number does not equal PDL. PDL is usually not determined for continuous 
cell lines, although it can be estimated by calculations. [20, p. 4]     
3.4 Environmental conditions of cell culture 
As stated before, one of the main advantages of cell culture is that environmental condi-
tions surrounding cells can be kept rather constant. However, these conditions may not 
be fully determined and some variation might occur, especially when using animal de-
rived substances like serum and natural substrates. There are at least five environmental 
aspects to consider which influence cell growth in a culture. These include physicochem-
ical and physiological composition of the culture medium, the constitution of the gas 
phase, the incubation temperature, the degree of contact with other cells, and the nature 
of the culture substrate [6, pp. 6, 31].  
 
Degree of contact with other cells was shortly described in the previous chapter, and it is 
also related to the choice of culture substrate. The required culture conditions vary for 
each cell type [17], and some common considerations are introduced here.  
 
3.4.1 Culture substrate 
Cells are traditionally cultured in culture vessels: glass petri dishes, plastic culture flasks 
or plastic multiwell and microtiter plates. [6, p. 31], [14] Thus, usually the culture sub-
strate for adherent cells is a glass or plastic (most commonly polystyrene) surface. Cells 
adhrere to glass with a slight negative charge, and also plastic vessels are treated by 
irradiation or chemically to produce a negatively charged surface. [6, p. 31], [19, p. 862] 
Extracellular matrix (ECM) proteins and proteoglycans, which cells secrete, attach to the 
negative charge of the surface and cells then attach to these proteins via specific receptors. 
Cell attachment is often improved by coating the surface with ECM proteins, such as 
collagen, laminin, or fibronectin, before adding cells; or the surface can be pre-condi-
tioned with other cells. [6, p. 31], [19, p. 862] 
 
However, in monolayer, which cells form on this type of 2D surface, cells lack three-
dimensional cell-cell and cell-matrix interactions which are present in vivo. Therefore, 
several 3D structures have been attempted to create as cell culture substrates. [6, p. 31] 
One example of such 3D environments is hydrogels, which are looked into in more detail 
in Chapter 5. 
 
3.4.2 Culture medium 
Several culture media are available commercially for different cells. Most of these so 
called basal media require additional serum supplement, most frequently 5–20 % of the 
 16 
volume. Fetal or newborn calf are most typical sources of sera, but human and equine 
sera are sometimes used. Serum adds important components to the medium, including 
hormones, growth factors, transport (binding) proteins, enzyme cofactors, lipids, and at-
tachment factors. Serum has some level of batch-to-batch variation: concentrations of 
serum components vary and they are affected by the age and health of the donor animal. 
[19, p. 864] 
 
Serum-free media offer the opportunity to culture cells without any animal derived ingre-
dients, which decreases the risk of introducing contaminants to the culture. It also allows 
complete control of the content of media without batch-to-batch variation. Furthermore, 
certain growth-inhibitory components of serum are avoided. Several serum-free media 
are available commercially. [19, pp. 862–865] If cells that are regularly cultured in a se-
rum containing medium are transferred into serum-free medium, an adaptation period is 
required, whereby serum percentage is gradually reduced. [19, pp. 862–865] 
 
In serum free media, cells may express lower attachment levels to a (plastic) surface. [19, 
pp. 862–865] This is understandable, because several proteins in serum attach to the neg-
ative charge in the surface of the vessel and cells attach to the proteins with their specific 
receptors. This needs to be taken into account when planning tests for cell attachment. 
 
Factors such as pH, osmolality, and ion concentration and composition should be consid-
ered not only with growth medium but also with other substances when conducting ex-
periments with cells. For certain cell types like myocytes and neurons, concentration of 
ions is especially crucial for their normal function and, therefore, using chelating agents 
such as EDTA in experiments requires careful consideration. [31, p. 4956] Also extracts 
that may be released due to degradation from biomaterials that are used as cell culture 
substrates need to be considered, as they may change the pH and ion composition of the 
culture environment.  
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4. SELECTING FIBROBLAST CELL LINE 
Based on the previous chapter, it can be concluded that primary cells, stem cells, and stem 
cell derived differentiated cells are more representable of the cells in vivo than cell lines. 
However, these cells can be hard to acquire, expensive, or require time to be differentiated 
from stem cells. In addition, they have a larger “batch-to-batch variation” (or from patient 
to patient) than cell lines. Therefore, for the first-step cytocompatibility testing, a cell line 
was preferred. Properties of a few common fibroblast cell lines were compared in order 
to choose a fibroblast cell line for the cytocompatibility screening. 
The ISO standard 10933:5 [14] includes useful considerations when testing cytocompat-
ibility of new medical materials. The standard recommends cell lines shown in Table 4.1 
as suitable cell lines for cytotoxicity tests. Most of these cell lines are fibroblasts, with 
the exception of Vero, which is a kidney cell with epithelial morphology [32]. As the 
standard merely provides a recommendation, other cell lines may be used if they can be 
shown to lead to the same or more relevant results [14]. 
Table 4.1 Cell lines suggested by ISO 10993-5 [14] for cytotoxicity testing. Information 
compiled from [6] and [21]. 
General name ATCC 
number 
Cell type Tissue Species 
NCTC  
clone 929 
CCL 1 Fibroblast Subcutaneous  
connective tissue: 
areolar and adipose 
Mouse (C3H/An) 
Balb/3T3  
clone A31 
CCL 163 Fibroblast (Embryonal) Mouse (BALB/c) 
MRC-5 CCL 171 Fibroblast Lung Human 
WI-38 CCL 75 Fibroblast Lung Human 
Vero CCL 81 Epithelial Kidney Monkey (Grivet) 
BHK-21  
(C-13) 
CCL 10 Fibroblast Kidney Hamster (Syrian) 
V-79 379A  Fibroblast  Lung Hamster (Chinese) 
 
In addition to the recommendation in ISO 10993, NCTC clone 929 (commonly known as 
L929 or L-929) has been used in standards ASTM F813 [33] and ASTM F895 [34] for 
cytotoxicity testing of materials intended for biomedical use. These ASTM standards fa-
vor L929 because it is widely used in cytotoxicity testing and it is a well-characterized, 
established cell strain that is readily available and has demonstrated reproducible results 
in several laboratories. [33], [34] Though in many cases L929 is referred to as a cell line, 
it is in fact a cell strain. L929 was isolated in 1948 by capillary cloning from a mouse L-
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cell, which, in turn, is a fibroblast cell strain derived from subcutaneous connective tissue 
(areolar and adipose) of a C3H/An mouse (Mus musculus) [6, pp. 1, 41], [35]. L929 was 
the first cloned cell strain ever generated [35]. Figure 4.1 presents the fibroblast-like mor-
phology of L292 cells.  
  
 
Figure 4.1 NCTC clone 929, also known as L929, in low density (left) and high density 
(right). [35] 
 
Among the cell lines recommended in ISO 10993-5, only two cell lines are derived from 
human sources: MRC-5 and WI-38. In the protocol developed in this thesis, human source 
can be seen as an advantage, as the ultimate aim is to test hydrogels for human tissue 
applications. MRC-5 and WI-38 are both finite fibroblasts from normal (non-diseased) 
fetal lung tissue [36], [37]. Although these cells are not immortalized, they proliferate 
extensively. MRC-5 cells are capable of 42 to 46 population doublings before onset of 
senescence, and WI-38 cells have an approximate lifetime of 50 ± 10 doublings. They are 
both commonly used cell lines and, especially, frequently used as feeder cells. [6, pp. 40, 
200, 223], [36], [37] Figures 4.2 and 4.3 illustrate the morphology of MRC-5 and WI-38 
cells grown on a 2D surface. 
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Figure 4.2 Morphology of MRC-5 fibroblasts in low density (left) and high density 
(right). [37] 
  
 
 
Figure 4.3 WI-38 cells, imaged before cryo-preservation. [38] 
  
In addition to the suggested fibroblasts in [14], human foreskin fibroblasts (hFF) are often 
used in in vitro cell models. They are commonly used as feeder cells [39], [40], but also 
in biomaterial research [41], [42]. Commercial hFFs are harvested from newborn males, 
and there are several human foreskin fibroblast lines available commercially (for exam-
ple, HFF-1, Hs27, Hs68, and CCD-1112Sk) [21]. Also hFF cells go through many popu-
lation doublings in culture before senescence. One of the commercial hFF lines, CCD-
1112Sk (ATCC CRL-2429) has anticipated life span of around 60 population doublings 
[43]. Further properties of L929, MRC-5, WI-38, and CCD-1112Sk are presented in Ta-
ble 4.2 
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Table 4.2 Properties of four fibroblast cell lines. 
Property L929 MRC-5 WI-38 CCD-1112Sk 
Age of source 
tissue 
adult 
fetal  
(14 week gesta-
tion) 
fetal  
(3 months gesta-
tion) 
newborn 
Species mouse human human human 
Source tissue 
clone of L-cell  
(subcutaneous con-
nective tissue) 
lung  lung  foreskin 
Culture prop-
erty 
adherent adherent adherent adherent 
Immortality continuous finite finite finite 
Ploidy aneuploid diploid diploid - 
Disease neoplastic no no - 
Serum require-
ment 
yes yes yes yes 
Reference [6, p. 201], [35] [6, p. 200], [37] 
[6, p. 200], [36], 
[38] 
[43] 
 
As can be seen in Figures 4.1 - 4.3, the morphology of WI-38 and MRC-5 cells is longi-
tudinally more spread than that of L929. Moreover, it can be seen advantageous, that WI-
38 and MRC-5 are diploid and derived from non-diseased sources ([36]–[38]), as they 
likely better represent normal growth characteristics and attachment to materials. Thus, 
for the purpose of this protocol, WI-38 and MRC-5 cells seem to be better options than 
L929. The only practical difference between WI-38 and MRC-5 is found in their maxi-
mum population doublings, which is slightly higher for WI-38 [36], [37]. hFF cell line 
CCD-1112Sk also has very similar properties to WI-38 and MRC-5 cells (Table 4.2). 
However, literature available on CCD-1112Sk is not as vast as in case of WI-38 cells, 
which have been used in research extensively. Therefore, WI-38 cells are favored for the 
screening protocol. 
 21 
5. HYDROGELS AS CELL CULTURE SUB-
STRATES 
Hydrogels are hydrophilic polymer networks that absorb large amounts of water, while 
maintaining their structural integrity in the swollen state [3]. Hydrogels may absorb from 
10–20% up to thousands of times their dry weight in water [1]. The network is formed by 
crosslinking the polymer chains chemically or physically. This water-containing network 
structure allows hydrogels to form a three-dimensional material. General properties of 
hydrogels include considerable biocompatibility, soft and tissue-like physical properties, 
and high permeability of small molecules. [1], [2] Hydrogels can be biodegradable or 
stabile depending on the constituting materials and crosslinking density. [44] Because of 
these properties, which resemble the ECM of tissues in vivo, hydrogels are interesting 
materials for cell culture substrates. 
 
Hydrogels can be fabricated from natural or synthetic polymers, and even their combina-
tion. Natural hydrogel polymers include hyaluronic acid, alginic acid, chitosan, polyly-
sine, collagen (and its derivate gelatin), fibrin, agarose and gellan gum. [1], [45] Examples 
of synthetic polymers include poly(ethylene oxide) (PEO), poly(vinyl alcohol) (PVA), 
and polypeptides [44]. Naturally derived hydrogels (such as collagen and Matrigel®) are 
considered as the gold standard for 3D cell culture substrates, because of their physical 
properties; although, they may suffer from batch-to-batch variation, limited design op-
tions and poor handling characteristics. [7] Synthetic polymers, on the other hand, have 
the advantages of controllable and repeatable chemistry and properties, but they may lack 
biological cues needed for interactions with cells [7], [44].  
 
When linear polymer chains are crosslinked with an agent that forms covalent bonds be-
tween the chains, the hydrogel is called chemically crosslinked, thermosetting, or perma-
nent hydrogel. Disadvantage of using crosslinking agents that form strong permanent hy-
drogels is that they are mainly toxic and unreacted agent has to be leached out. In addition, 
it is impossible to leach out partially reacted agents. This limits the usage of chemically 
crosslinked hydrogels. [2]  
 
In contrast, in physically crosslinked (or irreversible) hydrogels the polymer chains are 
held together by molecular entanglements or secondary forces, including ion bonding, 
hydrogen bonding, or hydrophobic forces. [1] Physically crosslinked hydrogels have the 
advantages of avoiding usage of toxic crosslinking agents, ease of fabrication, and possi-
bilities for modification after crosslinking. The major disadvantage is weak mechanical 
properties in swollen state, although this can be improved by copolymerization. [2] 
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Further, there are stimuli responsive hydrogels, or smart hydrogels, which rapidly and 
notably respond to small environmental changes by changing their network structure, me-
chanical strength, swelling behavior, or permeability. These environmental changes can 
be classified as chemical, physical or biomedical. For example, smart hydrogels exist that 
respond to temperature, pH, ionic factors or glucose level changes in their environment. 
[2] 
5.1 Puramatrix® hydrogel  
PuraMatrix® (registered trademark of 3-D Matrix) is a synthetic, commercial hydrogel. 
PuraMatrix® (PM) is composed of a repeating unit of three common amino acids, arginine 
– alanine – aspartic acid – alanine, which are coupled as a short peptide chain of 16 amino 
acids. These peptides, prepared in an aqueous solution, self-assemble into nanofibers 
when exposed to physiological salt concentration. Therefore, the hydrogel can be formed 
by adding culture media. The nanofiber density and average pore size (5-200 nm) can be 
controlled by the concentration of peptide solution when preparing the hydrogel. [46]  
 
PM forms a weak hydrogel. This structure might have its advantages especially when the 
cells are isolated from the gel for further analysis. However, it is also fragile and needs to 
be prepared and handled with caution. The hydrogel is colorless and transparent, which 
is beneficial for observing encapsulated cells microscopically. Because it is fully syn-
thetic and no human or animal source nor recombinant method has been used in the man-
ufacturing, PM is ensured to be pure, well defined, reproducible and lack the risk associ-
ated with biogenic sources. [47] 
 
PM has been shown to be biocompatible and to support growth and differentiation of 
many anchorage-dependent cell types [47]. For example, human progenitor neurons [8], 
hECS derived neuronal cells [48], and cartilage cells [49] have been cultured with Pura-
Matrix® as the cell culture substrate. 
5.2 Gellan gum hydrogels 
Gellan gum is an anionic linear polysaccharide. Gellan gum is derived from a fermenta-
tion product produced by a bacteria Sphingomonas elodea (ATCC 3146, formerly classi-
fied Pseudomonas elodea; also referred to as Sphingomonas paucimobilis). [45], [50] 
Gellan gum is produced with a high yield with this bacterial strain and it has a wide range 
of applications. Most commonly gellan gum is known as a gelling, stabilizing and sus-
pending additive in food and personal care products, for which gellan gum has U.S. Food 
and Drug Administration (FDA) and European Union (EU) approvals (E number E418 in 
EU). [50] In addition, gellan gum has been used in various controlled drug delivery ap-
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plications, plant and bacterial cultures, and studied as a mammalian tissue culture sub-
strate [50]–[52]. Depending on the application area, gellan gum is sold commercially un-
der several product names, such as Gelzan (CP Kelco) [45], [50]. 
 
The gellan gum polymer chains consist of a repeating tetrasaccharide unit of 1,3-β-D-
glucose, 1,4- β-D-glucuronic acid, 1,4-β-D-glucose, and 1,4-α-L-rhamnose. In water the 
polymer chains are in random-coil conformation (disordered conformation) at high tem-
perature (> 40 °C). When cooling the temperature, the chains transition into ordered con-
formation, which is a three-fold left-handed double-helix. [45], [50]  
 
Due to the helical structure, gellan gum may have properties of a weak gel when cooled. 
However, cations are required to form a true hydrogel network by aggregating helices. 
Divalent cations, such as Ca2+ and Mg2+ form bridges between helices by binding car-
boxyl groups of two double helices. Monovalent cations, such as Na+ and K+, produce 
weaker gels, and their use is based on suppressing electrostatic repulsions between the 
negatively charged carboxyl groups. [45], [50], [51] Carboxyl groups in the polymer 
chain also allow a variety chemical modifications of gellan gum. This way properties, 
such as stability in vivo and mechanical properties, can be altered. [45] 
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6. METHODS FOR TESTING CYTOCOMPATIBIL-
ITY 
Common parameters that are evaluated in direct contact cytotoxicity or cytocompatibility 
testing include attachment of cells to the surface material, and proliferation, viability (cell 
death, lysis or membrane integrity) and general morphology of cells [14], [33] (see also 
Chapter 7.5). These parameters can be assessed by various methods (assays), few of 
which are introduced in this chapter. The presented methods measure cell behavior 
roughly in two ways: either microscopically (imaging based methods) or by quantifica-
tion with a plate reader (colorimetric or fluorometric assays).  
 
Imaging based methods may precede staining or labelling cells with a (fluorescent) sub-
stance, and are followed by image analysis [9]. Imaging based method allows qualitative 
assessment of cells, but especially with image analysis software several attributes can be 
also quantified [9], [14, p. 9]. Colorimetric assays are based on a reagent that is converted 
into a colored substance and can be therefore measured with a spectrophotometer, i.e. 
measuring absorbance of light in the sample. Similarly, fluorometric assays are based on 
a reaction product that is fluorescent (i.e. a fluorophore), and which can be detected with 
a fluorometer. [9], [52]  
6.1 Cell viability 
The total number of live cells can be determined by the tetrazolium reduction assays, 
resazurin reduction assays, and protease activity assays. These assays measure general 
metabolism or an enzymatic activity of cells, which are indicators of cell viability. In all 
of these methods, cells are incubated with a reagent, which viable cells convert into a 
measurable colored of fluorescent substrate. [53]  
 
An example of tetrazolium reduction based assays is MTT (3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide) assay. MTT is yellow until reduced, after which it 
forms purple formazan. The reduction occurs due to enzymatic reactions in metabolically 
active cells. For that reason, it can be used as a measure for proliferation or viability of 
cells, as the formation of formazan is directly correlated to enzymatic activity. The purple 
color can be quantified with a spectrophotometer. [53], [54] MTT assay is an endpoint 
assay, because of formazan crystals forming in cells. Similar, newer, versions of MTT 
assay are MTS ((3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulpho-
phenyl)-2H-tetrazolium), XTT (2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazo-
lium-5-carboxanilide), and WSTs (Water Soluble Tetrazolium Salts) assays. [53]  
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Another, rezaurin reduction based, viability (and proliferation) assay is alamarBlue assay. 
The assay uses an oxidation-reduction indicator that changes color and becomes fluores-
cent as a result of chemical reduction of growth medium due to metabolic activity of cells 
[9]. It allows the number of living cells to be quantified by fluorometric measurement; 
also absorbance can be measured, but it is less sensitive than fluorescence measurement. 
This assay is relatively inexpensive and it is more sensitive that tetrazolium assays. The 
needed incubation time is 1-4 h. [53] 
 
An imaging based approach, which can also be used as a fluorometric assay, is Live/dead 
viability assay. Live/dead cell viability assay is conducted by using fluorescent dyes 
which allow distinguishing live and dead cells. There are several such dyes available 
commercially. One such option is using calcein-AM (Ca-AM) and Ethidium homodimer-
1 (EthD-1). Cells are dyed with both dyes at the same time. The incubation time is short, 
only about 30 minutes for 2D culture. The dyed cells can be observed or measured with 
flow cytometry, fluorescence microscopy, and with fluorescence microplate readers. [55] 
Live/dead assay has been used previously also with hydrogels. [41], [56] 
 
Non-fluorescent calcein-AM enters all cells, after which (in live cells) esterase activity 
converts it to fluorescent calcein by acetoxymethyl ester hydrolysis.  Ubiquitous intracel-
lular esterase activity is characteristic for live cells. Moreover, calcein as a polyanionic 
dye remains inside live cells well, thereby forming a strong, uniform green fluorescence. 
Calcein is green-fluorescent (excitation/emission maxima ~494/517 nm). [55], [57] Cell 
membrane integrity is a sign of cell viability. EthD-1 is cell-impermeant, unless the cell 
membrane is damaged. Therefore, EthD-1 enters only dead cells. In cells, EthD-1 binds 
to nucleic acid. EthD-1 is weakly fluorescent until bound, after which it emits red fluo-
rescence (excitation/emission maxima ~528/617 nm). [55], [58] 
 
6.2 Proliferation  
Viable cells can be proliferating or non-proliferating. Proliferating cells go through DNA 
synthesis and mitosis (so called (S) phase and (M) phase in cell cycle) to produce two 
daughter cells. Therefore, assays that measure viability of cells include both non-prolif-
erating and proliferating cells, but assays that specifically measure proliferation of cells 
do not detect all viable cells. [9] 
 
One common colorimetric immunoassay for measuring specifically proliferation is based 
on 5-bromo-2´-deoxyuridine (BrdU). BrdU is a pyrimidine analogue which is incorpo-
rated in place of thymine into the synthesized DNA of proliferating cells. Cells are incu-
bated with BrdU usually 2 - 24 h. Fixation of cells and denaturation of DNA is needed 
after incubation, however this is easy and fast, around 30 min, with a fixing and denatur-
ation solution included in the assay kit. [59] 
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BrdU is detected by staining with an anti-BrdU antibody conjugated with peroxidase, and 
a following substrate reaction, such as with TMB (tetramethyl-tetramethyl-benzidine). 
The reaction product is a colored substance, which can be quantified by measuring the 
absorbance in specified wavelength by using a scanning multiwell spectrophotometer, 
such as ELISA (enzyme-linked immunosorbent assay) reader. The absorbance correlates 
with amount of DNA synthesis in the cells of the sample, and thereby with number of 
proliferating cells. The benefit of using a multiwell ELISA reader is that a large number 
of samples can be analyzed simultaneously. [59] 
6.3 Cell attachment 
The simplest way of assessing attachment of cells to a material, is to count the number of 
cells on a material microscopically after a short culture time. For example, cell nuclei can 
be stained with fluorescent DNA stain such as Hoechst 33342 (bisbenzimide) or DAPI 
(4,6-diamidino-2-phenylindole) after a short culture time (for example 10 min). Cells are 
imaged and the number of cells (nuclei) is counted and compared to a control material 
[60]. Simultaneously, cells can be stained with other methods, such as with fluorescent 
dye phalloidin, which allows observing cell morphology (as described later). [61] Attach-
ment of cells inside a hydrogel has been studied by scanning electron microscopy of fixed 
and dehydrated hydrogels. [62]  
 
In addition, adhesion of cells to the material can be studied by staining adhesion mole-
cules in cells. These molecules include integrins, paxillin, vinculin, focal adhesion kinase 
(FAK), and tensin [60]. Adhesion studies the interaction between the material and cell 
more specifically. 
6.4 Morphology 
Morphology is observed by staining cells with molecules that locate in or bind to specific 
compartments or structures of cells. The molecules are either fluorescent themselves or 
are attached to another, fluorescent molecule. For example, cytoskeletal F-actin of fibro-
blasts can be stained with rhodamine-labelled phalloidin and cell nuclei are commonly 
stained with DAPI (4',6-diamidino-2-phenylindole). [7] Plasma membranes can be 
stained, for example, with Dil stain (1'-dioctadecyl-3,3,3',3'-tetramethylindocarbocyanine 
perchlorate). [60] After staining, morphology can be observed microscopically and im-
aged, but the fluorescence can also be measured with a plate reader [7].  
 
 
  
 27 
EXPERIMENTAL PART 
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7. INTERVIEW ON EXPERT PERSPECTIVE  
This thesis was made in collaboration between Biomaterial research group of BioMed-
iTech (Tampere University of Technology) and Regenerative Medicine research groups 
of BioMediTech Institute (University of Tampere): Heart group, Mesenchymal stem cell 
group, Ophthalmology group, and Neuro group. The research in each of the Regenerative 
Medicine groups focuses on cells from the respective tissues (cardiomyocytes, mesen-
chymal stem cells, corneal epithelial cells, retinal pigment epithelial cells, and neuronal 
cells). 
 
The aim of the cytocompatibility screening protocol created in this thesis was to offer 
these research groups a tool for screening hydrogels that could be finally used as a cell 
culture substrate for their cells of interest. As the cells used by the research groups are 
different, the interview was conducted in order to discover requirements that each of the 
research groups have for the screening protocol. In addition, the laboratory work of this 
thesis includes practical considerations that are difficult or impossible to know only based 
on the literature. Instead, working with live cells requires experience in cell culture of the 
particular cell type and its analyzing methods. 
 
For this reason, professionals in the Regenerative Medicine research groups were inter-
viewed to get their perspective on three main topics: criteria of a representable cell line 
that suits for cytocompatibility screening of their cell type (i.e. determining a suitable cell 
model); interactions of their cells of interest with surrounding (hydrogel) biomaterial; and 
analysis methods they would recommend using. One or two persons were interviewed 
from each Regenerative Medicine group of BioMediTech. The interview was conducted 
in fall 2015. Interview questions were based on Chapter 3, where effects on cell culture 
repeatability were investigated. The interview questions are in Appendix 1. Chapter 7.1 
introduces the general criteria for the cell line(s) that will be selected for the screening. 
The results of the interview are presented in chapters 7.2-7.5 and compiled in table form 
in Appendix 2.  
7.1 General requirements for all cell models 
In order to use a cell for repeatable testing of material cytocompatibility, the cell (with its 
culturing techniques) should result in minimal biological variation in attachment, prolif-
eration, viability and cell type specific functions when grown on substrates (such as hy-
drogels) that are cytocompatible. However, the cell should show decrease or variation in 
these results due to unfavorable change in culture substrate, such as a cytotoxic hydrogel.  
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Required properties of the cell model are as follows: 
 commonly used and readily available 
 not too expensive to acquire or culture 
 well characterized and standardized  
 relatively easy to culture, yet sensitive enough not to grow in an unsatisfactory 
hydrogel 
 stabile; as repeatable growth as possible  
 growth rate high enough so that it can be used in short time screening  
 adherent i.e. anchorage dependent cell  
The cell line should be commonly used in order to have enough literature to compare 
results with, and readily available so that this protocol could be generally accessible and 
repeatable. Many cells that are acquired from an acknowledged cell repository, are both 
readily available and well characterized and standardized by the repository (cell identity, 
purity, and safety are tested). As the aim is to study cell behavior with a material, adherent 
cells are required. In addition, because the screening is desired to be rapid, a short culture 
time is preferred. Therefore, the used cells should have high enough proliferation rate.  
7.2 Criteria for different cell models 
Most interviewed research groups preferred the species of the cell origin to be human, 
because animal derived cells can behave differently. Also, some biomarkers are specific 
for human cells, and therefore it is easier to use analysis methods that have been used 
with human cells. In cardiomyocyte model the species of the cell origin was not as sig-
nificant, and animal derived cells are often used in research. It is also noteworthy, that 
human derived, stabile neurons can be restricted in availability and price. 
 
The source of cells was preferred to be young in age, except in case of cell lines, when 
the age of the cell source has no significance. Especially in neuronal cell model, other 
than adult cells were required, because young and developing cells mimic the properties 
of neurons (from central nervous system) the best: they have better abilities to migrate 
and to form neuronal networks than adult cells. Neuroblastoma cells are an exception to 
this: they can originate from an adult (or child, more specifically), but because they are 
tumor cells, these adult cells are acceptable. For mesenchymal stem cell model, required 
age of the source depends on the application; adult cells might suffice for first step screen-
ing if they grow sufficiently. However, cells from a young individual would be better, 
because they allow producing a long-lasting cell line more easily, without gene transfor-
mation. In case differentiation is tested, mesenchymal stem cells would be needed.  
 
All groups agreed that continuous cell lines would be a better option than finite cells, in 
order to achieve reproducibility. Although, it was suggested that in case finite cells are 
used, cells should be able to proliferate enough to be subcultured to large quantities and 
cryopreserved, and then early passages could be used in all experiments. Furthermore, 
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even though a continuous cell lines would be better for repeatability, continuous cardio-
myocyte cell lines do not have the characteristic electrophysiological features, i.e. they 
do not beat, like primary cardiomyocytes do. Therefore, finite fibroblasts were suggested 
as the first step cell model for cardiomyocytes. 
 
Transformed and tumor cell lines divided opinions among groups. Some transformed and 
tumor cells attach and proliferate well on almost any material, which raises a question of 
representativeness of natural cells, especially when studying attachment to material. 
Transformed (immortalized) cell lines were considered suitable for corneal epithelial 
(CE) and retinal pigment epithelial (RPE) cell models (in vitro), even though the results 
should be considered approximate because of their different attachment properties. Tu-
mor cells, on the other hand, were not considered representative cells in applications of 
the Ophthalmology group. For neuronal model, both transformed and tumor cells would 
be suitable, as long as it has been proven with a negative control that the cell line does 
not grow too easily (on any material). Also for cardiomyocyte model transformed cell 
lines would be acceptable.  
 
Because the transformation to induce immortalization can occur anywhere in the cells, 
transformed cells were not considered an acceptable option for mesenchymal stem cell 
model. Commercial tumor cell lines, such as osteosarcomas, have been studied exten-
sively, and because the vast base of earlier research results, tumor cell lines were consid-
ered as the best option for the model (in addition to mesenchymal stem cells). Tumor cells 
and transformed cell lines do, however, behave differently than, for example, osteoblasts. 
Further, as for natural cells, early passages of finite fibroblasts from a young individual 
have growth properties nearly equal to those of a continuous cells line, and fibroblasts are 
used in research related to mesenchymal stem cells.   
 
Cloning cells was not recommended by any of the groups. Cloning would require addi-
tional work for characterizing the cells, for example, and compared to the effort, cloning 
was not seen necessary. Especially if a cell line can be used, cloning would offer no ben-
efits. In addition, further changes might occur in the cells during cloning. 
7.3 Representative cell lines 
Ideally, the chosen cell model should represent cells of interest of each research group. 
Research groups identified their ideal cell type, and cells that they are using currently in 
their studies. Research groups also recommended cells for the screening protocol (Table 
7.1) 
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Table 7.1 Cells that each cell model should represent, cells in use in the research groups 
currently, and recommended cells for the screening protocol. 
Cell model 
Should  
represent 
(Mimicking) cells in 
use 
Recommended cells 
Neuronal cell 
model 
any young  
CNS cell 
iPS derived neurons,  
hNP1,  
hESC derived neu-
rons 
SH-SY5Y [63], 
hNP1 [64], 
iCell [65], 
fetal neural progeni-
tors / neural stem 
cells 
Corneal epithe-
lial cell model 
corneal  
epithelial cell  
hiPS derived CE 
cells,  
HCE-T 
HCE-T [66] 
Retinal pig-
ment epithelial 
cell model 
retinal pigment epi-
thelial cell 
 
hiPS derived RPE 
cells,  
human primary RPE 
cells,  
ARPE-19 
ARPE-19 [67] 
Cardiomyocyte 
model 
differentiated cardio-
myocyte 
primary rat cardiomy-
ocytes,  
END2,  
PA6 
fibroblasts,  
(continuous cardio-
myocyte) 
Mesenchymal 
stem cell model 
mesenchymal stem 
cell 
fibroblasts,  
sarcomas 
mesenchymal stem 
cells 
sarcomas (SAOS-2) 
[68],  
fibroblasts  
 
The cells of interest in Neuro group, especially in biomaterial research, are central nerv-
ous system (CNS) neurons. Neuro group commonly uses (young) neurons differentiated 
from hESCs and iPS cells. In addition, hNP1 cells (ArunA Biomedical) have been used. 
hNP1 cells are commercial human neural progenitor cells, which have been derived from 
hESCs [64].  
 
For neuronal cell model, four types of cells were recommended (Table 7.1). SH-SY5Y, a 
human neuroblastoma cell line [63], was recommended because it has been extensively 
used in research and it is easy to culture. SH-SY5Y cells do not, however, form neuronal 
networks like hNP1 cells do, which were recommended because of this property. Neither 
of these cell lines had been used by Neuro group in biomaterial experiments before, there-
fore, behavior on unfavorable substrates had not been tested. Further, iCell® Neurons [65] 
were recommended because they are iPS derived neurons (“first step” of differentiation 
completed), and therefore correspond fully the cells of interest in Neuro group. iCell® 
Neurons are mixed populations of human cerebral cortical neurons (glutamatergic and 
GABAergic neurons) that exhibit native electrical and biochemical activity, including 
formation of neuronal networks [65]. They are also stated to exhibit long-term viability 
and demonstrated reproducibility [65]. As the fourth option, fetal neural cells (stem cells 
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/ progenitor cells) were recommended, that have also gone through the first step of dif-
ferentiation.  
 
The two cells of interest of Ophthalmology group, that the cell models should represent, 
were corneal epithelial cell and retinal pigment epithelial cell. In Ophthalmology group, 
clinically relevant retinal pigment epithelial (RPE) cells and corneal epithelial cells (CE) 
are produced from human pluripotent stem cells lines. The differentiation of these cells 
is a long process; at least 3 months for RPE cells. These human pluripotent stem cell line 
derived cells are challenging to culture, they are slow and suffer from batch to batch var-
iation and variation between cell lines. Ophthalmology group also uses human primary 
RPE cells, but these can be cultured only for few passages. In addition, the group has 
commercial immortalized cell lines ARPE-19 (RPE cells) and HCE-T (corneal epithelial 
cells) in use. 
 
Even though these immortalized cell lines, ARPE-19 [67] and HCE-T [66], behave rather 
differently on biomaterials compared to the stem cell derived cells and primary cells, they 
were recommended for the first-step screening model. That is because they are commonly 
used cell lines in Ophthalmology research and quite stabile cells. The most important 
criteria for both cell types is that they form an epithelial cell layer, have correct morphol-
ogies and express correct marker proteins, which can be detected with immunostaining. 
Corneal epithelial cells form a multilayered structure on the border of material surface 
and air. RPE cells, however, should stay as a monolayer. ARPE-19 cells should not be 
cultured too long (3-4 d), because they lack the property of stopping proliferation due to 
contact inhibition. In addition, ARPE-19 cells do not produce pigment, like RPE cells in 
vivo. Otherwise, ARPE-19 and HCE-T were considered to represent well human retinal 
pigment epithelial cells and human corneal epithelial cells. 
 
The cardiomyocyte cell model should represent a differentiated cardiomyocyte. The 
Heart group had used rat primary cardiomyocytes (harvested by the group), END2 cells 
(from mouse, a clone from P19 embryonal carcinoma cells [69]; and used to differentiate 
stem cells to cardiomyocytes [70]) and PA6 cells (also named MC3T3-G2/PA6, commer-
cial cell line from mouse bone marrow [71], [72]). However, according to the Heart 
group, there is not really another cell that mimics differentiated cardiomyocyte very well. 
Instead, the properties of the chosen cell line are more important to consider. The most 
important properties are, that the cell has to spread and take contact to other cells. There-
fore, quite many cell lines can be used, if the aim is merely to see whether the cell attaches 
and spreads on a material (in a fibroblast-like manner). PA6 cell line is similar to END2, 
but it was suggested that a fibroblast would be better option for the screening model. In 
addition, it was suggested that a continuous human cardiomyocyte cell line could possibly 
be a good option, if available, although, these cells do not beat. 
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For mesenchymal stem cell (MSC) model, the cells should represent MSCs that can be 
used in bone and cartilage applications. The cells that could be used for the model are 
fibroblasts, osteosarcoma cells (for example, SAOS-2 [68]) and chondrosarcoma cells. 
Although there are some disadvantages of using tumor cells, they give repeatable results 
and grow more rapidly than osteoblasts and chondrocytes, hence tumor cells were con-
sidered a better option for screening. SAOS-2, which is an osteoblast-like sarcoma, has 
the advantage of being extensively used in research relating to bone tissue.  
7.4 Culture environment 
Possible applications of hydrogels in the research areas of Regenerative Medicine re-
search groups included three-dimensional cell culture, disease modeling, and drug and 
toxicity resting. Further, in future, hydrogels could have tissue engineering applications, 
such as acting as a scaffold in central nervous system transplantation therapy or heart 
patch after ischemia.  
 
For these applications, the aim is to ultimately culture neurons, cardiomyocytes, and mes-
enchymal cells inside the hydrogels (encapsulated in hydrogel or in “sandwich” layout, 
i.e. cell layer between two hydrogels). In addition, cells could be cultured on top of hy-
drogels to study their attachment to the hydrogel. In RPE and CE applications, hydrogels 
have the advantage of being transparent. The role of a hydrogel in CE applications would 
be to mimic the structure of the stroma of the eye and cells would therefore only be cul-
tured on top of hydrogels. This represents the layout of corneal cells in the eye, there the 
cells are in the substrate-air interface. Also RPE cells are required to grow only on top of 
hydrogels. In case of RPE model, the hydrogels do not need to be macroscopic in their 
thickness. In fact, for retina applications, hydrogels may not be best approach, as the op-
timal substrate was described as an extremely thin (4-20 µm) yet mechanically durable 
biomimetic porous sheet.  
 
Research groups were asked to recommend positive and negative controls, preferably hy-
drogels, for the screening of new hydrogels based on the cells that are currently used in 
their research. Many research groups had not tested culturing their cells with hydrogels 
before, or hydrogels were not in regular use. Therefore, they could only suggest some 
options to try (Appendix 2 (2/3)), and also recommended two-dimensional controls. For 
example, collagen was suggested as a potential positive 3D control. However, it must be 
noted, the positive and negative controls depend on the final application. Especially in 
MSC model, the difficulty with many hydrogels is that cells form soft tissue or fat tissue, 
not bone or cartilage.  
 
Commercial hydrogels, PuraMatrix® and Matrigel®, have been used previously by Heart 
group. Also Neuro group has cultured neuronal cells with PuraMatrix® in different lay-
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outs with good results [48]. As controls with neuronal cells, uncoated well (negative con-
trol) and laminin-coated well (positive control) have been used. A negative hydrogel con-
trol was not in regular use of Neuro group. Some options for possible negative hydrogel 
controls were mentioned to include unmodified PEG (polyethylene glycol), chitosan, and 
unmodified cellulose. 
 
Many cells require a coating with a biomolecule before plating them on culture flasks. 
This should be considered separately for each cell that is used, when choosing control 
materials. In general, for cardiomyocytes gelatin coating is routinely used. The commer-
cial immortalized cell lines HCE-T and ARPE-19 grow almost on everything and do not 
necessarily need any additional coating. However, with stem cell derived RPE and CE 
cells additional ECM proteins are needed. MSC cells attach to uncoated well, so coating 
is not needed, although 3D scaffolds are sometimes incubated in culture medium before 
inserting cells. Neurons require a laminin coating. According to interview, this coating 
should be only considered for 2D control, and not with hydrogel, when aim of the screen-
ing is to test cell reaction towards hydrogel, and when the location of laminin in the sam-
ple (or level of attachment of laminin to hydrogel) is not known.  
 
All other groups except MSC group culture their final cells of interest (for example, in 
Ophtalmology group hiPS derived RPE and CE cells) in serum free medium or medium 
with serum replacement. Because proteins in serum can affect attachment of cell to ma-
terial, this aspect can be taken into consideration when choosing the cell model, so that 
its requirements for serum would be the same as in final application. However, cell lines 
are usually adapted to a certain culture medium, and according to the interview, re-adap-
tation to different serum conditions in medium is time demanding and not recommended.   
7.5 Analysis methods 
All groups recommended 3-5 parallel samples for experiments. In addition, several cell 
lines could be used in some cases to better validate the results and give more information, 
especially if the used cells are derived from stem cells (for example, hiPS derived CE 
cells) or primary cells (should be collected from several patients). For first step screening, 
generally one cell line was considered sufficient. Later the results could be proven to be 
reliable with a more representable cell (for example, starting with a sarcoma cell line and 
validating results with MSCs or osteoblasts). 
 
Research groups described aspects of cellular behavior that need to be observed in order 
to determine response of their cells of interest toward a material. In addition, they recom-
mended methods to analyze these aspects. These are listed in Appendix 2 (3/3). All groups 
needed to observe at least proliferation or viability of cells and morphology cells, even 
though the methods to detect these varied. 
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The culture time that is needed to observe cell response to hydrogel differed between cell 
types. Neuronal cells and MSCs needed 2-week culture time. Culturing for one week was 
said not to suffice for neuronal cells, because cells might grow well for one week, but 
retract after that. For differentiation of MSC, 4 weeks is needed, however, testing differ-
entiation is out of the scope of this thesis. To observe response of HCE-T cells and fibro-
blasts, 1-week culture was recommended. For ARPE-19 cells culture time of 3-4 days 
was recommended, although proliferation can be detected already after culturing for one 
day. (Also, detecting formation of mature RPE monolayer would take 28 – 42 days.) In 
general, attachment of cells, however, can be observed right away. 
7.6 Conclusion 
Based on the interview, we can conclude that the cytocompatibility testing can be made 
in different steps. Before using more specialized cells such as stem cells, neural progeni-
tor cells or hiPS / hESC derived differentiated cells, an immortal cell line or a tumor cell 
line should be used (Table 7.2). These immortalized cell lines and tumor cell lines are 
easier to culture, have high repeatability and have been used extensively in research, of-
fering a base for comparing results. However, the behavior of these proposed cell lines 
should be checked on negative controls before taking into use, in order to confirm that 
they are sensitive enough. 
 
Table 7.2 The proposed cells to be used for each cell model in the three phases of cyto-
compatibility screening protocol. The first step is common to all cell models. 
Cell model 1st step 2st step 3rd step 
Neuronal cell 
model 
Fibroblast 
(WI-38) 
SH-SY5Y 
iPS derived neurons (eg. iCell®);  
hNP1 (Aruna) hESC derived neurons;  
fetal neural progenitors / neural stem 
cells 
CE cell model HCE-T 
hiPS derived CE cells; 
human primary RPE cells 
RPE cell model ARPE-19 
hiPS derived RPE cells;  
human primary RPE cells 
Cardiomyocyte 
model 
END2,  
PA6,  
continuous car-
diomyocyte 
primary rat cardiomyocytes,  
 
Mesenchymal 
stem cell model 
Osteosarcomas, 
chondrosarco-
mas (SAOS-2) 
Mesenchymal stem cells 
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For cardiomyocyte model, fibroblasts were considered the best option for the first-step 
screening. Because no other cell than cardiomyocytes really represent (beating) cardio-
myocytes very well, morphology was considered as the most important property. Fibro-
blasts are rather easy cells to culture, and because of their “fibroblast-like” morphology 
they should generally spread on their culture substrate. Fibroblasts were mentioned as an 
option also for MSC model for first-step screening. In addition, a few fibroblasts were 
recommended by ISO 10993-5 standard for general cytotoxicity testing of materials [14]. 
Therefore, the cytocompatibility screening could be started by using fibroblasts, regard-
less of the final cell of interest. This first step would give information about the cytotox-
icity of the material in general. Based on comparison made in Chapter 4, it can be con-
cluded that WI-38 would be the most suitable fibroblast for this particular screening pro-
tocol. After testing with fibroblasts, testing can be continued with immortal cells and tu-
mor cells (Table 7.2). 
 
Choice of control materials, culture time before analysis, and whether culture medium 
will be supplemented with serum are aspects that depend on the cell model that is used in 
each step. Even though using serum-free medium would be desirable in many final appli-
cations, a compromise has to be made to choose a suitable cell line.  
 
Within the limits of Master’s Thesis, only the first step was optimized in this thesis.  In 
this case, WI-38 cells are adapted to serum supplemented medium, hence, serum would 
be used, even though this might affect attachment to materials and can cause some batch-
to-batch variation. PuraMatrix® has been proven to be cytocompatible with many cell 
types, including fibroblasts (see Chapter 5.1). Because PuraMatrix® was mentioned by 
two groups and can therefore be useful in further steps as well, it was chosen as positive 
(3D) control. Attachment and viability were chosen to be studied by Live/dead staining 
method. 
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8. DEVELOPMENT OF CYTOTOXICITY PROTO-
COL TO STUDY NOVEL HYDROGELS 
Based on the results of the interview (Chapter 7) and the literature, the following protocol 
is recommended for screening hydrogel cytocompatibility for cell culture applications 
(Figure 8.1).  First, attachment, viability, proliferation and morphology of cells are tested 
by using a general cell line, such as a fibroblast cell line. After that, more tissue-specific 
cell lines are used to study the same phenomena. The tissue specific cell line depends on 
the cell type intended to be used in the final application. For example, in case of mesen-
chymal stem cells, a sarcoma cell line can be used as a representable cell line (Appendix 
2). Finally, the same phenomena are studied with the intended cell type for the final ap-
plication, such as stem cells, differentiated cells or primary cells. Testing specific func-
tions of cells or staining cell-specific structures becomes especially relevant in parts 2 and 
3 (Figure 8.1).   
 
 
Figure 8.1 Parts of the hydrogel cytocompatibility testing protocol for cell culture appli-
cations. First-step cytotoxicity testing protocol, which tests short-term attachment and 
viability of a general cell line, was created in this thesis (marked with green). Other parts 
of the protocol (marked with red) were left out of the scope of this thesis. 
 
Within the scope of this Master’s thesis, a protocol for screening attachment and viability 
of a general cell line (steps 1A and 1B in Figure 8.1) was optimized and tested in practise. 
Morphology of cells was assessed qualitatively only as a reference when needed, in order 
to validate the protocol. According to definitions in Chapter 2.1, these parts of the proto-
col, when tested with a short culture time, indicate short-term cytotoxicity of a material. 
Steps 1A-B can be therefore considered as a “first-step” cytotoxicity protocol. This pro-
tocol is based on principles of direct contact cytotoxicity testing in standard ISO 10993-
5:2009 [14].  
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Optimizing and testing of other parts of the cytocompatibility protocol (1C, 1D, 2 and 3) 
were left for future experiments. However, similar principles as defined in this thesis can 
be used for testing attachment and viability of the more specialized cells (in steps 2 and 
3). In addition, a longer culture time than 1 – 2 days could be later used to better represent 
the needs of the research groups (Chapter 7).  
 
The purpose of the first-step cytotoxicity protocol would be to screen attachment and 
viability of cells seeded on top and encapsulated in hydrogels. As stated earlier in Chapter 
2.2, cytotoxicity (and, therefore, cytocompatibility) can be evaluated either quantitatively 
or qualitatively. The analysis method was chosen to be an imaging based, because it can 
offer both qualitative and quantitative information. Cells were observed qualitatively 
from fluorescence and phase contrast images. However, even though qualitative assess-
ment would be suitable for screening cytotoxicity [12], a quantitative approach was pre-
ferred in this thesis to obtain a more high-throughput protocol, and so that effects of small 
differences between new hydrogels could be detected. Therefore, attachment and viability 
were quantified from fluorescence images.   
8.1 Research methods and materials  
Figure 8.2 represents the workflow of the experiments that were made and the parameters 
relating to each step. These parameters were optimized for the attachment and viability 
screening protocol. The experiments for optimizing the parameters are introduced in the 
following subchapters.  
 
A set of materials and methods were selected based on literature and the conducted inter-
view (cell line, control materials and staining method). The imaging system (equipment) 
was selected by comparing the suitability of three imaging systems: BioStation CT (Ni-
kon), Cell-IQ (CM Technologies), and ApoTome (Zeiss). Further, other experimental pa-
rameters were optimized based on an iterative sequence of several experiments. Each ex-
periment gave results for several parameters, which are, in addition, interconnected with 
each other. For example, the working distance of imaging system is one of the most im-
portant factors in defining the maximum volume of the sample that can be imaged. On 
the other hand, the material affects the practicalities of sample preparation, such as the 
minimum volume in which a hydrogel can be formed (as well as maximum volume). 
Because imaging a three-dimensional, transparent sample is rather different than imaging 
a monolayer of cells, optimizing the imaging acquisition settings was especially focused 
on. 
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Figure 8.2 Overview of the workflow of experiments and the parameters that were opti-
mized relating to each step. 
Briefly, the workflow of the experiments was as follows. Fibroblasts were cultured on top 
of and encapsulated in 3D macroscopic hydrogels and on control materials. After 2 h – 3 
d culture time, cells were imaged with phase contrast microscope of BioStation CT, which 
was the main imaging system in the experiments. Cells were then stained with 
LIVE/DEAD® viability/cytotoxicity kit (Molecular probes, ThermoFisher Scientific) and 
phase contrast and fluorescent images were then taken from the same imaging points. 
Obtained images were analyzed with ImageJ software (FiJi distribution, open source [73], 
[74]). Cell viability and attachment on top or inside the control and test materials were 
assessed quantitatively from fluorescence images. 
8.1.1 Sample preparation 
Sample layouts are schematically presented in Figure 8.3. Cells were plated on top of 
hydrogels (“OnGel”) or encapsulated inside hydrogels (“3D”). A commercial hydrogel, 
BD™ PuraMatrix™ (BD Biosciences), was used as a positive three-dimensional control 
(both for OnGel and 3D samples). In addition, gellan gum (GG) hydrogels crosslinked 
with spermidine (SPD) were tested. SPD is a polyamine which allows physical crosslink-
ing of gellan gum [52]. Cells were always plated also on uncoated well-plate (“2D”), 
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which acted as the positive (two-dimensional) control and a reference for imaging. Un-
treated polydimethylsiloxane (PDMS) discs were used as the negative (two-dimensional) 
control. PDMS does not elicit negative, cytotoxic reactions [75], but it is  an inert material 
because of its high hydrophobicity, and does not support cell attachment or growth, unless 
treated with suitable plasma treatment [61]. PDMS also has the advantage of being trans-
parent.  
 
 
Figure 8.3 Schematic illustration of test and control sample layouts prepared for the ex-
periments. 
 
Test and control samples were prepared according to the following common instructions, 
unless stated differently in particular experiment. The numbers of replicate samples in 
experiments varied between 2 and 6. 
8.1.1.1 Cell culture 
A commercial human embryonic lung fibroblast cell line WI-38 (Sigma-Aldrich / Culture 
Collections, Public Health England) was chosen based on the literature review and inter-
views and used for most experiments. WI-38 cells were cultured with DMEM/F-12 
growth medium supplemented with 10% FBS (fetal bovine serum), 1.25% Glutamax, and 
0.5% Penicillin/Streptomycin. WI-38 cells were subcultured twice a week with 1:2 ratio 
(or seeding density of 2-4×104 cells / cm2). WI-38 cells with passages 19-34 were used 
for experiments (p. 21-27 for attachment and viability assessment tests). 
 
In addition, a few experiments were made with human foreskin fibroblast (hFF) cell line, 
CCD-1112Sk (a kind gift from the Ophtalmology group, BioMediTech). hFF cells cul-
tured with IMDM growth medium supplemented with 10% FBS and 0.5% Penicil-
lin/Streptomycin. Cells were subcultured once a week with 1:5 ratio. hFF cells with pas-
sages 10-13 were used for experiments. All cells were stored in sterile conditions at 37 
°C and 5% CO2. 
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After thawing from cryopreservation, cells were cultured at least a week before using for 
experiments, as is recommended [14] to allow cells retain their normal functions. For 
preparing samples, cells were washed twice with DPBS and detached with trypsin (5-10 
min incubation). Trypsin activity was stopped with full (supplemented) growth medium, 
unless cells were encapsulated in gellan gum. FBS accelerates gelation of gellan gum, 
which makes sample preparation difficult, and in that case unsupplemented growth me-
dium was used. 
 
Samples were made to Nunc™ Multiwell plates (Thermo Scientific), treated with Nun-
clon™ Delta surface treatment, or to CELLSTAR® Cell Culture Multiwall plates (Greiner 
Bio-one). For initial experiments (testing equipment and Live/dead staining concentration 
conditions), CCD-1112Sk cells were plated on 2D and on top of hydrogels with density 
of 5 × 104 cells / cm2 and encapsulated in (GG) hydrogel with the density of 100 and 200 
cells / µl of hydrogel (in Nunc™ 48 well plate).  
 
Later, different seeding densities of WI-38 were tested on 2D controls and on top of hy-
drogels (Table 8.1) and encapsulated in hydrogels (Table 8.2). Recommended seeding 
density of WI-38 cells is 2-4×104 cells / cm2. However, in order to be able to distinguish 
cells from one another well, cell densities slightly under the recommendation were also 
tested.  
 
Table 8.1 Seeding densities of WI-38 on two-dimensional controls and on top of hydro-
gels. Seeding densities are announced in (cells / cm2), because in addition to using 24- 
and 48 well plates, the area of wells in well plates of different manufacturers differ from 
each other. 
Well plate 
Cell density  
(cells / cm2) × 104 
Nunc 24 wp 
1.7 
2.0 
2.8 
4.0 
CELLSTAR® 48 wp 
1.5 
1.7 
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Table 8.2 Cell densities (WI-38) encapsulated inside hydrogels. 
Well plate 
Cell density 
(cells / µl of hydrogel) 
Nunc 24 wp 
350 
600 
CELLSTAR® 48 wp 
500 
600 
 
8.1.1.2 Gellan gum hydrogel 
Gellan gum (Gelzan, Sigma-Aldrich) and spermidine (Spermidine trihydrochloride, 
85578, BioXtra, ≥ 99.5 % (AT), Sigma Aldrich) stock solutions were prepared in 10 % 
sucrose. The spermidine (SPD) (1.0 mg/ml) stock solution, gellan gum (GG) 5 % stock 
solution (5 mg/ml) and sucrose solutions were sterile filtered with 0.2 µm filter. GG so-
lution was heated to 60 °C in water bath (or dry bath) prior to sterile filtering in order to 
decrease viscosity. After sterile filtering, solutions were handled aseptically. Two con-
centrations of SPD were used to crosslink hydrogels for experiments: 1.0 mg/ml and 0.5 
mg/ml. These concentrations correspond to volume ratios of 3% and 1.5% of SPD in the 
final hydrogel, respectively. 
 
Crosslinker and gellan gum solutions were warmed to 37 °C prior to gelation. Hydrogel 
samples were prepared my mixing the crosslinker (SPD) and gellan gum in a well-plate 
in SPD:GG volume ratio 160:1000. The solutions were mixed by stirring with pipette tip 
or pipetting up and down (if gelation was slow enough). When possible, well-plate was 
kept on a 37 °C hot-plate during mixing and gelation. Gelation time depends on the cross-
linker concentration, and gelation was observed by tilting the well-plate; when no flow 
was seen, the hydrogel was considered to be gelated. Hydrogel volumes of 145 µl – 290 
µl were tested. 
 
When cells were cultured on top of the hydrogel, the hydrogel was prepared first. After 
the hydrogel had properly gelated, cell suspension (cells in supplemented medium) with 
correct cell concentration was simply pipetted on the hydrogel. When cells were encap-
sulated inside the hydrogel, the crosslinker and cell suspension (cells in medium without 
serum supplement) with correct cell concentration were first pipetted into the well. There-
after, gellan gum was added and solutions were mixed. Medium without serum supple-
ment was used, because serum decreases the gelation time of GG, which makes it more 
difficult to prepare homogenous samples. The volume of cell suspension was kept under 
10% of the total volume of the hydrogel, in order not to compromise the mechanical 
properties of the hydrogel. Medium with serum supplement was added on the hydrogel 
sample after gelation. 
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8.1.1.3 PuraMatrix™ hydrogel 
BD™ PuraMatrix™ peptide hydrogel (PM) stock solution (10 mg/ml, 1 % w/v) was ac-
quired from BD Biosciences. Hydrogels (0.5 % w/v) were prepared according to Pura-
Matrix™ instructions. Volume of PM hydrogels was 200 µl. PM stock solution was vor-
texed to decrease viscosity and bubbles. For OnGel samples, 200µl of 0.5% PM solution 
(diluted in 10% sucrose solution) was pipetted into each well. PM was first crosslinked 
with WI-38 growth medium and the medium was changed twice during one hour, before 
adding cells (1.7 × 104 cells in each well). 
 
For 3D encapsulated samples, cells were suspended in 10% sucrose solution to a concen-
tration double the final concentration (in this case 1.2 × 106 cells / ml, to obtain final 
concentration of 600 cells / µl of hydrogel). 100 µl of the cell suspension was mixed 
slowly with 100 µl of 1 % PM solution. After mixing, the mixture was immediately trans-
ferred into a well and crosslinked by slowly adding WI-38 growth medium. The samples 
were prepared individually to decrease the time cells must stay in contact with PM and 
sucrose solution without medium, because the pH of PM is not favorable to cells before 
adjusting it with growth medium. Samples were stored in incubator and medium was 
changed twice during one hour to equilibrate pH.  
8.1.1.4 Poly(dimethylsiloxane) 
A large poly(dimethylsiloxane) (PDMS) disc was prepared from Sylgard® 184 Silicone 
Elastomer Kit. The disc is made by pouring correct amount of PDMS solution on a plastic 
disc and then heated for crosslinking. Therefore, the upper and bottom sides of the disc 
were different, as one faced plastic and the other faced air during preparation. Small discs 
were cut out with an 8.5 mm diameter biopsy punch. The discs were 820 µm – 950 µm 
thick.  
 
The discs were moved into sterilization bags, while keeping them facing the same direc-
tion (air side facing the paper and plastic side facing plastic of the bag or aluminum folio 
inserted into the bag). The discs were sterilized by autoclaving (Tuttnauer Autoclave 
2540ELLB) in 121 °C for 15 min. 
8.1.1.5 Live/dead assay 
Control cells, and cells on top and encapsulated inside hydrogel were cultured approxi-
mately 2 h to 3 d before staining with LIVE/DEAD® viability/cytotoxicity kit (Molecular 
probes, Thermo Fisher Scientific). In brief, the two dyes of the kit, calcein-AM (Ca-AM, 
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stock 1 mM, λemission = 488 nm) and ethidium homodimer-1 (EthD-1, stock 2 mM, λemission 
= 568 nm) stain live and dead cells, respectively.  
 
Because the staining solution can be assumed to dilute in the water-containing hydrogel, 
three concentrations (single to triple concentration of EthD-1 and Ca-AM) in the staining 
solution (in PBS) were tested (Table 8.3).  
 
        Table 8.3 Tested concentrations of LIVE/DEAD® staining solution. 
 EthD-1 (µM) Ca-AM (µM) 
C1 0.05 0.10 
C2 0.10 0.20 
C3 0.15 0.30 
 
The volume of staining solution in each well was the same as volume of replace medium 
(e.g. for 48-well plate 500 µl). After 20 min - 1 h incubation at +37 °C the cells were 
imaged with one of the imaging systems. 
 
8.1.2 Imaging systems 
CM Technologies Cell-IQ, Nikon BioStation CT, and Zeiss ApoTome were tested as the 
possible imaging systems. Cell-IQ and BioStation CT are both cell culture imaging sys-
tems, which include an incubator and imaging hardware. They are automated systems, 
where the imaging points can be set in the operating software. Phase contrast images and 
fluorescence images can be taken with these systems. Zeiss ApoTome imaging system 
included Zeiss Axio Imager M2 upright Microscope, which is a wide field fluorescence 
microscope. It was equipped with ApoTome unit, a structured illumination system, which 
allows optical sectioning of the sample.  
 
Because Zeiss ApoTome imaging system was equipped an upright microscope, samples 
could not be prepared in 24- or 48- multiwell plates. Otherwise the objective lens would 
not reach close enough to the samples (edges of the well are on the way). Therefore, 
hydrogels were made in Nunc 24-well plates with Ø = 13 mm glass coverslips in the 
bottom. In addition, similar samples were made into 5 ml cut syringes that had been ster-
ilized (Figure 8.4). 145 - 290 µl GG 1.5% SPD hydrogels were prepared.  
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Figure 8.4 Gellan gum hydrogel in a cut syringe. Red color comes from incubation in 
cell culture medium. 
After gelation, WI-38 cells (1.6×104 cells / cm2) were seeded on top of hydrogels. Cells 
were stained with Live/dead assay solution and after 30 min incubation in room temper-
ature, the staining solution was removed. Before imaging with ApoTome imaging system, 
samples were lifted together with the cover slip or pushed out from the syringes into a 6-
well plate (or on its lid) (Figure 8.5).  
 
 
Figure 8.5 Gellan gum hydrogels transferred from 5 ml syringes to well plate lid for 
imaging with ApoTome. On the left 145 µl, in the middle 200 µl and on the right 290 µl 
samples. 
Both Cell-IQ and BioStation CT were tested with 290 µl gellan gum samples casted in 
Nunc 48-well plate. CCD-1112Sk cells were encapsulated in (GG 3% SPD) hydrogels 
(100 and 200 cells / µl gel) and plated on top of hydrogels and uncoated wells (5×104 
cells / cm2). After 3 days, cells were first observed with phase contrast microscope in the 
imaging systems, and after staining, imaged with fluorescence and phase contrast micro-
scopes. 
 
BioStation CT was also tested with thinner hydrogels: gellan gum hydrogels (3% SPD) 
with volumes of 145 µl and 174 µl were prepared in Nunc 24-well plate. In addition, 
CELLSTAR® (TC treated) 48 well-plates (Greiner Bio-one) well plates were tested with 
145 µl, 200 µl, 250 µl, and 290 µl gellan gum (1.5% SPD) hydrogels. Cells were seeded 
on top and encapsulated in samples. 
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Usability of the three imaging systems was compared, especially in terms of imaging 3D 
hydrogels in high-throughput manner. Also the focusing ranges of the systems and sample 
volumes that could be imaged fully were compared. In well plates used with BioStation 
CT, focus position of the inner surface of the well was observed (where cells on uncoated 
wells were in focus).  
8.1.3 Image acquisition settings in BioStation CT 
Several different test series were conducted to optimize image acquisition settings in Bi-
oStation CT. In case of PDMS and uncoated well, the surface on which cells were grow-
ing was flat, and therefore this focus plane was the target of imaging. However, in case 
of hydrogels, cells are located in different focal planes. In encapsulated samples this is 
because cells are inside the hydrogel, but also cells on top of hydrogels are located in 
different focal planes to some extent, because of uneven surface. To get a representable 
set of data from samples, the aim was to image encapsulated samples from several xy 
coordinates in different planes in Z-axis. In order to prevent distortion of quantitative 
results, it was attempted to avoid imaging above the surface. For OnGel samples the aim 
was to image surface of the hydrogel, where cells were in focus (Figure 8.6). 
 
 
Figure 8.6 Principles of imaging cells on PDMS control, and encapsulated and on top of 
hydrogels. PDMS was a flat disk, on which cells were in one plane. The uncoated well 
had a similar layout, only in the bottom of the well.  Ideally encapsulated samples would 
be imaged from several focal planes (middle, left), however the topology should be con-
sidered, not to image above the surface (middle, right). Ideally, cells on top of hydrogels 
would also be imaged in one plane (bottom, left), but in reality the cells reside in different 
planes (bottom, right). Red dots illustrate possible imaging positions. 
PDMS 
3D 
OnGel 
theoretical  
surface 
real surface 
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Samples were imaged in BioStation CT with phase contrast microscope (Ph channel) be-
fore staining. After staining the same coordinates were imaged with phase contrast and 
fluorescence microscope (green and red channels) of BioStation CT. All samples were 
imaged with 4× and 10x magnification, and 1-15 images were imaged per sample. 
 
Imaging points were set either manually (custom points, user defines x,y, and Z coordi-
nates) or by using 5 default points. The latter is an option where x,y coordinates are pre-
set in the middle of the well and at equal distances around it; Z coordinate is defined by 
autofocus (i.e. optimal focus point calculated by the equipment).  
 
Custom points of hydrogel samples were set at the same x, y coordinates (Figure 8.7), 
and Z coordinates varied according to sample. Z coordinates on OnGel samples were set 
manually where cells on top of hydrogel sample were in focus. Information on Z coordi-
nates in those points was used to estimate the location of sample surface in encapsulated 
samples of the same experiment. Custom points in encapsulated samples were then set 
accordingly in 2-4 different planes inside the sample.  
 
 
Figure 8.7 Well map of imaging coordinates. Each square represents the area of well 
that is seen in live mode with 10x magnification on the operating panel of BioStation 
CT. 
 
Hydrogel samples were also imaged with phase contrast channel by using Z stacking 
(equal number of images are taken automatically below and above the autofocus or cus-
tom set Z coordinate). Range (i.e. total distance of stack) was 200 µm - 400 µm and pitch 
(distance between images) was 5 µm – 10 µm. In addition, Full scan function was used, 
which images the entire area of well in one focus plane (autofocus or custom set). Three 
focus planes with custom set Z coordinates were imaged separately in 3D samples. After 
imaging a focus plane with Full Scan function, tiling images were retrieved or imaged for 
some samples (2D and 3D). 
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8.1.4 Image analysis 
Images were analysed with FiJi software. Two fluorescence images were obtained in 
grayscale from each imaging point, one with each of the two channels they were imaged 
with (“green channel” and “red channel”). For observing RGB images, the two images 
(channels) were merged, and green and red colors were added by using FiJi. For effi-
ciently processing all images, a macro was written (Appendix 5). The macro opens im-
ages from all coordinates of one sample and merges the channels, and forms a stack in 
RGB format. 
 
For counting cells from the fluorescence images, the following circumstances were con-
sidered to count cells correctly either as dead or live. Usually, live cells are seen as uni-
form green fluorescent areas and dead cells are seen as uniform red fluorescent areas. 
However, green and red stains can be located seemingly in the same cell, or in the area of 
one cell, because of the following reasons. 
1. There is bleed-through to the opposite channel. The intensities that are observed 
should be very low.  
 
2. “False green” is seen, even though the cell is dead. Intensity of the cell (or nucleus) 
in red channel is high compared to its surrounding. At the same location and/or 
around the red area, there is an area in the green channel which is visible in low 
to high intensity. This is the cytosol of the cell, which, for some reason, still re-
mains fluorescent calcein inside it, even though the cytosol is dotted and the edges 
of the cell are not uniform or clearly defined.   
 
3. Two cells are on top of each other, one is dead and the other is live. Usually, but 
not always, a live cell is bigger than a dead cell. 
a. If the cells are in two-dimensional surface, or in the same focus plane in a 
hydrogel, these cells should have equally high intensity.  
b. If the cells in hydrogel are apart from each other in Z-axis, the intensity of 
cells also decreases when cells are located further away from the focus 
plane. 
Cells were counted from RGB images manually. Cells that were far from focus plane 
(only aberration ring visible) were omitted. “False green” cells were the most prominently 
double stained, and they were counted in addition to the number of red cells and green 
cells (include green and red cells that were double stained). To obtain the number of live 
cells and dead cells, the number of double stained cells was subtracted from the number 
green cells. The final number of dead cells was the same as number of red cells. 
 
Cells were also counted automatically with FiJi. The set of executed functions are pre-
sented in Particle Count algorithm, Appendix 4. The algorithm for counting was based on 
intensity differences in the image and cell size. It produces numbers of cells in green 
channel and red channel. In attempt to omit the same cells in automatic counting as in 
manual counting, high threshold values were used. The values for thresholding green and 
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red channels were estimated by measuring the minimum intensity of countable cells in a 
few images (Table 8.4, Threshold 2). Similarly, minimum size of cells that needed to be 
analyzed was estimated. 
 
The Particle Count algorithm was used to analyze 10x fluorescence images of one exper-
iment (2D and 3D samples). Cells were counted with the algorithm twice, using different 
threshold values (Table 8.4). The particle size was the same, 40 px2 - infinity, both times 
and for both channels. 
  
Table 8.4 Values used in the steps of Particle Count algorithm. Cells were counted twice, 
with two different threshold ranges. 
Step Red channel Green channel 
Threshold 1 100 – 255 100 – 225 
Threshold 2 100 – 255 130 – 225  
Analyze particles; size 40 px2 - infinity 40 px2 – infinity 
 
The final number of dead and live cells with automatic counting were the numbers of red 
and green cells, respectively. The numbers of live and dead cells obtained by the different 
manual counting and Particle Count algorithm were compared to estimate the accuracy 
of the algorithm. 
 
8.1.5 Assessment of attachment and viability 
For assessing attachment and viability of cells, numbers of live cells and dead cells were 
obtained from fluorescence images by manual counting (according to Chapter 8.1.4). At-
tachment of cells to a hydrogel was assessed with samples where cells were seeded on 
top of the hydrogel (OnGel samples). With this layout, unattached cells are removed dur-
ing medium change. The more cells are present on the material after medium change, the 
better the material supports attachment of cells.  
 
One approach to assess attachment would be to count cells on the samples before and 
after medium change. This would require counting cells from phase contrast images. Con-
trast between cells and hydrogel is low, especially when cells have a spread morphology, 
which makes counting more difficult than from fluorescence images. Also the image anal-
ysis in FiJi was optimized for fluorescence images, thus, another approach was chosen 
where fluorescence images were utilized. Cells that remained on the sample after the me-
dium change (in this case, change to Live/dead staining solution) were counted from flu-
orescence images. The number of all cells (live and dead) on the test hydrogel was com-
pared to the number of all cells on the control material.  
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The attachment in a sample was calculated relative to the positive 2D control (uncoated 
well plate), hence giving the 2D control a comparison value of 1. Simply, attachment was 
defined as in Equation 8.1.  
 
𝐴𝑡𝑡𝑎𝑐ℎ𝑚𝑒𝑛𝑡 =
 𝑐𝑒𝑙𝑙𝑠 𝑝𝑒𝑟 𝑖𝑚𝑎𝑔𝑒 𝑜𝑛 𝑠𝑎𝑚𝑝𝑙𝑒
𝑐𝑒𝑙𝑙𝑠 𝑝𝑒𝑟 𝑖𝑚𝑎𝑔𝑒 𝑜𝑛 2𝐷
                                         (8.1) 
 
The area covered by each image, when imaged with the same magnification, was assumed 
equal (cells assumedly in one focus plane). Because the number of images analyzed per 
sample can vary, average number of cells per image in each sample was used for the 
calculations instead of total number of cells in the sample. The attachment for each ma-
terial was calculated according to equations 1-4 in Appendix 3. 
 
Using OnGel samples, also viability of cells on the materials was calculated. This assess-
ment is coherent with more traditional direct contact cytotoxicity testing methods and is 
useful for cells that are only cultured on top of the hydrogels, not encapsulated in hydro-
gels (such as corneal and retinal cells). As the main focus in this protocol was to test 
viability of cells when they are encapsulated inside the hydrogel (3D), viability was also 
assessed using encapsulated samples. Viability was calculated in the same way for both 
sample layouts. 
 
The viability of cells in a sample was defined as in Equation 8.2 [56, p. 1388]. 
 
𝑉𝑖𝑎𝑏𝑖𝑙𝑖𝑡𝑦 =
𝑙𝑖𝑣𝑒 𝑐𝑒𝑙𝑙𝑠 𝑖𝑛 𝑠𝑎𝑚𝑝𝑙𝑒
(𝑙𝑖𝑣𝑒 𝑐𝑒𝑙𝑙𝑠 + 𝑑𝑒𝑎𝑑 𝑐𝑒𝑙𝑙𝑠) 𝑖𝑛 𝑠𝑎𝑚𝑝𝑙𝑒
                                 (8.2) 
 
The viability was calculated for each image according to Equations 1-4 in Appendix 3. 
Finally, the average viability in each material were compared. Especially, viability of 
cells in different materials is compared with that of the positive 3D control PM, to assess 
the properties of material in terms of supporting cell viability (i.e. “cell survival”). Stand-
ard deviations for viability and attachment were calculated by using (sample) standard 
deviation formula. 
 
Attachment and viability were assessed for cells on top of 2D, PDMS, PM and GG 1,5 % 
SPD. Samples were prepared according to the general instructions and parameters shown 
in (Table 8.5). Similarly, viability was assessed for cells encapsulated in PM and GG 
hydrogels, and cells on 2D for reference (Table 8.5).  
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Table 8.5 Sample preparation values and imaging settings of the assessed samples. At-
tachment and viability was assessed from OnGel samples, and viability was assessed from 
3D (encapsulated) samples.   
 Attachment and viability Viability 
Sample layout of hydrogels OnGel 3D 
Cells WI-38 p. 21 WI-38 p. 21-27 
Culture time 5 h 48 h 
Seeding density 1.7 × 104 / cm2 600 / µl (gel) 
Staining c1, 500 µl / well c1, 500 µl / well 
Incubation 1h 20 min, +37 °C 30 - 60 min, +37 °C 
Imaging Custom points, 10x, FL Custom points, 10x, FL 
 
The (theoretical) volume of both 3D and OnGel hydrogel was 200 µl and samples were 
made in CELLSTAR® 48 plate. The numbers of all parallel samples was 2, and samples 
were imaged with BioStation CT. At least 3 images (10x magnification) were evaluated 
for the cytotoxicity analysis per sample. 
 
8.2 Experimental results  
The results from experiments are presented in the following subchapters. The parameters 
that were found the best based on these results, were used to create a set of instructions 
for the first-step screening of hydrogel cytocompatibility. This protocol is found in Ap-
pendix 3, supplemented with Appendices 4-5 for image analysis. 
8.2.1 Sample parameters 
Cell density of 2.0 – 2.8 × 104 cells / cm2 was suitable for seeding WI-38 cells on uncoated 
well, PDMS, and on top of hydrogels. In these densities it was possible to separate cells 
from one another for counting, yet cells were presumably densely enough not to suffer. 
Although, especially at higher densities cells grew on top of each other in the middle of 
the well. In higher cell densities (4 × 104 cells / cm2) it was impossible to count cells, 
because they were overlapping each other. 
 
In encapsulated samples, 600 cells / µl (gel) was a better density than 350 cells / µl (gel) 
and cells could still be separated from each other. 350 cells / µl (gel) was too low density 
for effective observation. In fact, even in samples with 600 cells / µl cells were quite 
scarce. Encapsulating 100 – 200 cells / µl was definitely too low cell density, although in 
that experiment the whole hydrogel was not visible due to focus range restrictions. 
 
 52 
Staining concentration of 0.10 µM EthD-1 and 0.20 µM Ca-AM (double concentration) 
in PBS together with approximately 40 min incubation time in 37 °C produced the best 
imaging results. After 20 minutes of incubation in BioStation CT, condensation droplets 
under the well plate were interfering with imaging, and therefore minimum incubation 
time was limited already by the equipment. At least the double concentration is recom-
mended, because with single concentration cells were stained unevenly. 
 
In general, the hydrogel samples were difficult to prepare in a way that the thickness 
would be uniform throughout the sample. Gellan gum samples were thicker on the edges 
of the sample. PM become uneven easily because of its fragile structure and way of cross-
linking by adding culture medium on top of the PM solution. PM samples were slow to 
prepare and often did not succeed. 
8.2.2 Choice of imaging system 
Key advantages and disadvantages of BioStation CT, Cell-IQ, and ApoTome system for 
hydrogel screening purposes are summed in Table 8.6. ApoTome imaging system is more 
manual than BioStation CT and Cell-IQ systems, as it is possible to image only one x, y 
coordinate at a time. In BioStation CT and Cell-IQ systems, several imaging coordinates 
(imaging points) can be set first, after which the system will move the well plate and 
objective lens to image all set points automatically. In addition, several imaging rounds 
at separate time points can be taken from the same coordinates, which allows time-lapse 
imaging with these systems.  
 
Table 8.6 Advantages and disadvantages of tested imaging systems for hydrogel screen-
ing purposes. 
Equipment Advantages Disadvantages 
Cell-IQ  Imaging in incubator conditions. 
Time-lapse imaging, automated 
Cells move out of the focus and are hard to 
find after removing the plate from equip-
ment.  
Image size is large. 
Z coordinate not visible when operating. 
BioStation 
CT  
Imaging in incubator conditions. Imaging setting limitations. 
Imaging points stabile after re-
moving plate out of equipment. 
Time-lapse imaging, automated 
ApoTome 
system 
Flexible imaging range and pitch. 
Less automated. 
Z stack of fluorescence images is 
possible. 
Not usable with hydrogels in high-
throughput because of temperature and hu-
midity issues. 
Time-lapse imaging not possible. 
 Sample preparation more time-consum-
ing. 
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However, operating ApoTome system to obtain images at desired Z coordinates was easy. 
For example, to image a stack of images in one x, y coordinate, starting and ending coor-
dinates in Z axis could be entered numerically. This was faster opposed to Cell-IQ and 
BioStation, where Z coordinates of imaging points were set by first moving to the desired 
location in the sample by scrolling. It would be possible to add a motorized stage in the 
ApoTome system, which would make imaging even faster and more repeatable, when the 
same coordinates could be images in all replicate samples. Another advantage of Apo-
Tome system was high focusing range. It was possible to image all sample volumes, 145 
- 290 µl, fully with the ApoTome upright microscope. 
 
As the aim is to analyze the number of live and dead cells, live cells have to remain live 
during imaging. Because of that, also temperature, humidity and gas composition are of 
importance. The disadvantage of ApoTome system was the lack of incubator unit. When 
imaging hydrogels, it is important to retain the humidity stable. Now samples were re-
moved from culture medium, which caused samples to dry and shrink quickly. This was 
an unacceptable problem, as with the used experiment setup, the imaging was not fast 
enough to go through all samples before hydrogels suffered. In addition, the preparation 
of samples for imaging adds a slow step in the process, comparing to imaging samples in 
a well plate. Therefore, the system was not usable with hydrogels in high-throughput 
manner. Another type of sample preparation and preserving arrangements should be made 
to avoid temperature and humidity issues, in order for this system to be suitable for cyto-
compatibility screening in the desired scale. 
 
BioStation CT and Cell-IQ systems do have an incubator unit and well plates (or other 
culture flasks) are imaged below the well plate. Between these two similar imaging sys-
tems, BioStation CT was chosen, because of more informed operation (Z coordinate val-
ues were visible) and smaller image size. In addition, cells were noticed to move off their 
earlier imaging points in Cell-IQ after the well plate had been removed from the equip-
ment for medium change. In both systems, the focusing range was too small for 290 µl 
samples (in Nunc 48 well plates) that they were tested with. This issue was later resolved 
in BioStation CT, which became the main imaging system in further experiments. 
8.2.3 Focusing range and sample volume in BioStation CT 
The focusing range of BioStation CT did not cover the whole hydrogel with the initial 
experimental setup of 290 µl GG samples in Nunc™ 48-well plate (ThermoFisher Scien-
tific). The upper limit (maximum focusing position) was reached before cells on top of 
the hydrogel were seen.  
 
The problem was related to the moving range and working distance of the objective lens 
(Figure 8.8). The upper limit, i.e. maximum focusing position when the objective lens 
was at its uppermost position, was reached at Z = 4700 µm (distance from the holder 
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surface). The focus position of the inner surface of the well bottom (where cells on un-
coated wells were in focus) shall be defined here as the zero level (as it is the reference 
focusing position to compare different experimental setups). Further, the distance be-
tween the zero level and maximum focusing position shall be defined here as effective 
focusing range (EFR). In order to observe and image a hydrogel sample throughout its 
thickness, the sample should fit in between maximum focusing position and focusing po-
sition of the inner surface of the well bottom, that is, within the EFR.  
 
 
Figure 8.8 Focusing range in BioStation CT, and effective focusing ranges when using 
well plates from different manufacturers. (Picture: Yasujiro Kiyota, Nikon, reproduced 
with permission.) 
 
The obstacle of too short effective focusing range was approached with two possible so-
lutions: first, thickness of the samples was decreased, and second, a well plate with lower 
well bottom was tested. Decreasing sample size to 174 µl or lower in 24 well plate, was 
not a good solution for imaging full thickness of hydrogel. Smaller hydrogel volumes 
(145 µl and 174µl) were difficult to prepare in a 24-well (Nunc) plate in practice, because 
the gelation requires mixing of the crosslinker and gellan gum solution, and gellan gum 
gelates rather quickly. Therefore, it was difficult to obtain homogenous samples. Instead, 
the hydrogels tended to gelate more on the edges of the well and leave the middle of the 
well nearly or entirely empty. It was impossible to know, if the cells were then attached 
to a thin hydrogel layer, or rather the plastic well plate bottom. In either case, this made 
the setup unreliable.  
 
The problem with focusing range in BioStation CT was solved by using Greiner CELL-
STAR® 48-well plate, in which bottom of the well plate was lower than in Thermo Sci-
entific™ Nunc™ multiwall plate - and therefore closer to the objective lens in BioStation 
CT. Hydrogels with volume of up to 250 µl were entirely visible with CELLSTAR® 48 
well plate. Even 290 µl hydrogels were partially visible (in the central area of well), but 
on the edges of the well the hydrogel surface was above the upper limit (Table 8.7).  200 
Nunc 24 multiwell  
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– 250 µl hydrogels were the most successful volumes both from preparation and imaging 
perspectives.   
 
Table 8.7 Theoretical thickness of hydrogels in CELLSTAR® 48 well plate and volumes 
that were visible in BioStation CT. 
Volume (µl) Theoretical thickness (µm) Visible 
145 1422 Yes 
200 1961 Yes 
250 2451 Yes 
290 2843 Partially 
 
The zero level in CELLSTAR® 48 well plate was on average at Z = 3136.12 µm, which 
gives EFR of approximately 1600 µm (counted from the upper limit, 4750 µm – 3136.12 
µm = 1613.88 µm). This EFR value was consistent in repeated experiments and between 
imaging rounds; only small changes were seen due to human effect because of placing 
the well plate in holder. In Nunc well plates, the EFR (shown in Figure 8.8) was observed 
to be 885-1180 µm (there were differences between well plates and wells in single well 
plate). Thus, EFR in CELLSTAR® well plate was at least 420 µm longer than in Nunc 
well plates, which was a significant increase in the EFR. 
 
In both CELLSTAR® 24- and 48- well plates, the distance between the lower edge of the 
well plate (frame) and the inner surface of the well is 19 mm – 16.5 mm = 2.5 mm (+/- 
0.15 mm) [76], [77] (shown in Figure 8.8). According to Figure 8.8, this should leave a 
moving range of 4750 µm- 2500 µm = 2250 µm above the well surface before upper limit 
is reached. The EFR, however, does not directly correspond to the moving range of ob-
jective lens (as noted, EFR was 1600 µm versus 2250 µm (+/- 150 µm)).  
 
Table 8.8 indicates example volumes of hydrogels and their corresponding thicknesses 
calculated by the area of well in Nunc and CELLSTAR® well plates. (A(Nunc 24) = 180 
mm2, A(Nunc 48) = 113 mm2, A(CELLSTAR® 24) = 194 mm2, A(CELLSTAR® 48) = 
102 mm2.) According to Table 8.8, hydrogels with a volume of 100 µl – 200 µl that are 
prepared in CELLSTAR® 48 well plate should theoretically be thin enough to be visible 
within the effective focus range (EFR) of 2250 µm. Similarly, only 100 µl hydrogels 
would be visible in Nunc 48 well plate, within EFR of 885 – 1180 µm. 
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Table 8.8 Theoretical volumes and corresponding thicknesses of hydrogel samples pre-
pared in Nunc and CELLSTAR® 24 and 48 well plates. Thickness is announced in mi-
crometers. 
Volume (µl) 
Nunc well plate CELLSTAR® well plate 
24 48 24 48 
100 556  884 515 980 
145 806 1282 747 1422 
200 1111 1768 1031 1961 
250 1389 2210 1289 2451 
290 1611 2564  1495 2843 
 
From Table 8.7 it is also visible, that theoretical thickness of the hydrogel is not directly 
corresponding to the thickness that is seen optically in the microscope. Volumes that can 
be imaged fully, should be calculated according to physical volume (moving distance) 
above the surface of well plate volume. However, even though thicknesses counted in 
Table 8.8 are closer to moving range of 2250 µm, larger volumes were visible than can 
be estimated based on theoretical thickness. 
 
There are several factors that have to be taken into consideration to estimate the volume 
of hydrogel that can be imaged. First, real volume of hydrogel may differ from its theo-
retical volume, i.e. the sum of volumes of its components. This is because of the water 
containing structure of hydrogels. Second, the surface of the hydrogel can be curved, so 
that the difference in thickness between middle of the sample and edges can be several 
hundred micrometers (this was noticed especially in case of gellan gum hydrogels). Third, 
the working distance of the objective lens, its moving range in the equipment, and finally 
the diffraction of light in different materials, affect the effective focusing range. The plas-
tic bottom of the well and the water-containing hydrogels diffract light because of differ-
ent refractive indexes than that of air.  This changes the distance that objective has to be 
moved compared to the distance seen in the sample. 
8.2.4 Image acquisition in BioStation CT 
Imaging with phase contrast channel at the same position as with fluorescence channels 
was very beneficial. Phase contrast images provided additional information, and allowed 
to interpret the fluorescence images from a different view point, if there was any uncer-
tainty, for example, about the health of cells or whether they were inside hydrogels. A 
round of phase contrast imaging before staining also allowed saving the imaging points. 
This made imaging faster after staining, especially when custom points were used, and 
decreased incubation times with the staining solution, which would have been too long 
otherwise. 
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Magnification 
 
Cells could be counted from fluorescence images taken with both 4x and 10x magnifica-
tions. However, from time to time, in 4x magnification images it was not entirely possible 
to separate cells from one another accurately, whereas counting cells from 10x images 
was easier. In addition, with 10x magnification it is easier to avoid overlapping of the 
areas that are imaged. In 4x images taken with 5 default points, the imaged areas were 
noticed to partially overlap each other; same cells were visible in the images. Therefore, 
10x magnification is recommended. 
 
Coordinates in x,y plane 
 
During experiments cells were noticed to mostly reside in the central area (when cultured 
on 2D or on hydrogel) due to slight curving of the well bottom and hydrogel surface. In 
addition, samples in well plates are generally imaged in the middle of the well rather than 
on the edges for higher image precision, because of light diffracts due to the sides of the 
well and a slight curving of the well bottom. Only images from the centre of the well 
(coloured area in Figure 8.9), gave images with high enough precision and enough cells 
for counting. When images are taken from this area in all samples, results will be compa-
rable, because attachment and viability are counted by comparing average number of cells 
per image. Images that are taken with 5 default points also locate in this area.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8.9 Recommended map of imaging points in a well. The colored area corresponds 
to the area where cells were mostly located. In imaged points outside this area, cells were 
usually not present, hence images should be acquired from coordinates 1-5, or other 
points with similar distance from the center of the well (point 1).    
 
 
                             
                              
                               
                              
                               
        2          
                  
      5  1  4        
                  
        3          
                               
                               
                              
                              
                               
 
 58 
 
Focusing and Z coordinates 
 
Uncoated wells were successfully imaged with 5 default points with automatic focusing, 
which was a useful setting for these controls. Also tiling images could be taken from these 
2D controls with autofocus, to increase the number of images per well. Because autofocus 
works well with uncoated wells, it is beneficial to use it instead of custom focus, in order 
to save time in setting the imaging points. Autofocusing with PDMS controls worked well 
only after changing medium, otherwise unattached cells that were floating in the medium 
above PDMS shifted the focus level too high. With PDMS it also has to be checked that 
the autofocusing has not focused on the surface of the well (zero level). On the other hand, 
custom points were focused correctly, and as the discs were flat, it was not time-consum-
ing to set custom points manually. Therefore, custom points are recommended. 
 
Because of uneven topology of hydrogels, imaging points were set manually (10 custom 
points) on gellan gum OnGel samples. The Z values of these custom points are shown in 
Table 8.9. The table shows that surface of the hydrogel samples had a significant topo-
logical variation in the range of hundreds of micrometers, especially, but not limited to, 
rising toward the edges of well. 
 
Table 8.9 Average Z coordinates of 10 imaging points (set according to Figure 8.7)  
where cells on top of gellan gum hydrogels were in focus (if visible). 
Point 145 µl 200 µl 250 µl 290 µl 
1 3200 3507 3836 4032 
2 3200 3571 3748 4126 
3 - 3596 3900 4099 
4 3250 4254 3895 4113 
5 3750 3815 4148 4345 
6 4110 4453 4671 4750 
7 3500 3908 4200 4317 
8 - 4468 4662 4576 
9 3400 3844 4198 4415 
10 3890 4403 4683 4658 
 
 
Schematic illustration of the topology of hydrogels is presented in Figure 8.10. The top-
ological variations of surface were bigger than expected and caused a challenge in imag-
ing, because it was hard to predict the location of the surface of samples. Because of this, 
setting custom points was very time-consuming, but this allowed to estimate the needed 
coordinated for encapsulated samples.  
  
 59 
 
Figure 8.10 Schematic illustration of the shape of a hydrogel sample, cut into half. Hy-
drogels could be theoretically imagined to form a cylinder shaped sample with flat sur-
face when gelated into a well plate. In reality, the surface of the hydrogels curved down 
from the edges to the middle of the sample: difference in the thickness was up to several 
hundred micrometers. In addition, the surface topography was uneven in smaller (mi-
crometer) scale. 
Imaging hydrogels with autofocus gave conflicting results. In one experiment where cells 
on top of (145 µl) hydrogels were imaged with autofocus, cells were in focus in the re-
sulting images. On the other hand, in another experiment, autofocus focused in the well 
bottom and no information was retrieved from these images. In addition, the setback with 
autofocus is that information on the Z coordinate where the cells are imaged is not added 
to the data of images. Even theoretically, using 5 default points to image OnGel samples 
is not feasible when samples have large topological variation between the imaging coor-
dinates (distance from the center corresponds to points 1-4 in Table 8.9). That is because 
the Z coordinates for imaging all 5 points are equal, and defined by autofocusing in the 
center of the well (point 1).  
 
Similar, conflicting results were obtained for autofocusing in 3D samples. It can be con-
cluded that autofocusing is an unreliable way of setting imaging points in hydrogels, and 
whether it can be used depends largely on the samples. The more homogenous the sample 
is, the more likely autofocus will work, because uneven structures of hydrogel that are 
visible, would not distract the focusing. However, if autofocusing is an option due to 
homogenous samples, it is recommended to be used, because setting imaging points 
would be significantly faster. 
 
Because of problems with autofocusing, custom points were mostly used for setting the 
imaging points in hydrogels. In 3D samples (but not OnGel samples), it was possible to 
set custom points in one sample and copy them to all replicate samples. However, cells 
encapsulated in samples were not always distributed in the hydrogel evenly. Therefore, 
the number of visible cells in each image was not very high. Adding to this, copying 
imaging coordinates without focusing to certain cells further decreased the amount of 
cells in focus in images. To obtain enough data for analysis, the number of custom points 
could be increased. The colored area in Figure 8.9 covers 25 tiles (in 10x magnification), 
and the maximum number of custom points that can be set per well in BioStation CT is 
26.  
 
theoretical surface 
real surface 
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Another way to increase the number of images obtained from a sample was to image the 
sample with Full Scan function. Imaging several planes in 3D samples with Full Scan 
gave successful results. However, because the Full Scan function images all tiles at the 
same Z coordinate (defined by user of autofocus in the center tile of the well), this func-
tion was not convenient for OnGel samples. It must be noted, that only one Z coordinate 
per sample can be imaged with Full Scan at one time. 
 
Examples of images obtained from 2D, PDMS, GG and PM (OnGel and 3D) samples are 
presented in Appendix 6. The samples had been prepared according to Table 8.5 and im-
aged (more specifically) with settings described in Table 8.10. 
 
Table 8.10 Imaging settings that were chosen for attachment and viability assessment 
setup. 
Setting 2D PDMS OnGel 3D 
Observation points 5 default custom custom  custom  
Z coordinate autofocus custom custom custom  
Focusing autofocus custom custom  custom  
Copying points automatically 
set, no need 
no no yes 
Magnification 10x 10x 10x 10x 
Channels Ph, FL Ph, FL Ph, FL Ph, FL 
 
Limitations of BioStation CT 
 
A very big limitation in BioStation CT was that it is impossible to capture a Z stack of 
fluorescence images. This would have been useful in order to screen through the hydrogel 
in different depths. Z stacking is only possible with phase contrast channel, but in that 
case the information on cell viability is not obtained (other than by qualitative evaluation). 
It is also not possible to register custom points with different Z values to the same x,y 
coordinate for imaging in one experiment. 
 
Imaging a Full scan of one Z coordinate (custom set) was possible with fluorescent chan-
nels, but only one Full scan coordinate could be set per well at a time. Therefore, to image 
several Z values with Full scan, one needs to image one Z level, then return to the sample 
to update the Z scan value (by moving to the desired location), and schedule a new imag-
ing for this Z coordinate. 
 
Even more useful than a Full Scan of a level would be a tile of, for example, 4 x 4 images, 
because not all images in the Full Scan contain useful information (Figure 8.9). Tiling 
images were possible to obtain after imaging a Full scan. To obtain Tiling image with 
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custom focus, however, an additional step was needed (choosing a desired tiling to be 
downloaded from the list of Full Scan images).  
 
In addition, setting custom imaging points by entering coordinates numerically was not 
possible. This makes setting points slow when many points are set and when there are 
many samples to screen. Map of the well for planned moving in the operating panel and 
copying settings makes this a little faster. It must be remembered that copying settings to 
all parallel samples is an easier option that setting individual option, and it randomized 
the points, although in that case cells will not be in focus in all images. 
8.2.5 Image analysis 
The macro for opening images and converting to RGB was very helpful. The macro al-
lows processing images faster, and can be used before counting cells manually. If algo-
rithms are used in FiJi to process images, recording or writing macros is recommended 
for achieving more high-throughput protocol.  
 
Step for separating cells (watershed) in Particle count algorithm was not used in the cal-
culation of cells. Watershed function separates areas that should be counted as individual 
particles. Using Watershed function makes a 1 px line between these areas based on a 
narrower area between them. This function is beneficial in samples where many cells are 
close to each other. However, when cells were longitudinal, individual cells were cut to 
smaller pieces, because the outline of their morphology was not simply convex. This re-
sulted in cell numbers increasing falsely.  
 
Table 8.11 presents total numbers of green and red cells counted manually and automat-
ically by Particle Count algorithm in FiJi software with two threshold ranges. When 
counting cells manually, it was seen that approximately half of the cells that were stained 
red were also stained with green (double stained), and therefore, the number of double 
stained cells were counted as well. (In Table 8.11, double stained cells are counted as red, 
green and double stained.) Based on the high intensities of red and green, and dotted 
appearance of green in the same location, these cells were identified as dead cells. The 
green in these cells can be described as “false green”. Thus, the number of double stained 
cells was subtracted from the number of green cells to obtain the number of live cells. 
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Table 8.11 Total numbers of green and red cells counted manually and by Particle Count 
algorithm (two threshold ranges). Double stained cells were counted manually. Thresh-
old 1: red and green 100-255, threshold 2: red 100-255, green 130-255. Number of ana-
lyzed images was n = 15 for 2D and n= 20 for 3D (encapsulated) samples. 
Approach 
Sample 
layout 
Red Green 
Double 
stained  
Dead Live 
Manual 
2D 40 839 18 40 821 
3D 47 71 32 47 39 
Particle count 
Threshold 1 
2D 38 674 - 38 674 
3D 44 84 - 44 84 
Particle count 
Threshold 2 
2D 38 692 - 38 692 
3D 44 57 - 44 57 
 
Error of the total number of green, red, live and dead cells obtained by different automatic 
counting methods was calculated comparing to manual counting (Table 8.12). In both 
sample types, Particle Count algorithm produced a small error (5 - 6 %) in number of red 
cells. The error was slightly higher in number of green cells (18 - 20 %). Because of 
double staining, the error became large after the interpretation to live and dead cells. The 
error was especially large in 3D sample calculated with threshold values 100 - 255 for 
both channels. Rising the threshold of green channel to 130 - 255, which was the esti-
mated threshold range for green channel, decreased the error. This shows that some dou-
ble stained cells were filtered out (84 cells versus 57 cells). However, the error was still 
46% with this thresholding.  
 
Table 8.12 Error in numbers of cells counted by algorithm compared to manual counting. 
Threshold 1: red and green 100-255, threshold 2: red 100-255, green 130-255. 
Approach 
Sample 
layout 
Error Red 
(%) 
Error Green 
(%) 
Error Dead 
(%) 
Error Live 
(%) 
Particle count 
Threshold 1 
2D 5 % 20 % 5 % 18 % 
3D 6 % 18 % 6 % 115 % 
Particle count 
Threshold 2 
2D 5 % 18 % 5 % 16 % 
3D 6 % 20 % 6 % 46 % 
 
The error in counting green cells could be decreased with adjusting the used values of 
algorithm or other, additional image processing steps. It can be also concluded, that an 
algorithm to count double stained areas would be needed to complement the Particle 
Count algorithm.  
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It must be noted, however, that if the cells are cultured on 2D and have spread morphol-
ogy, a situation presented in (Figure 8.11) has to be taken into account. In the figure dead 
fibroblasts have nuclei stained red and the cytosol around it stained green, although with 
a smaller intensity and uneven color. Simply counting areas that are stained with both 
stains would not recognize these areas as double stained, because green and red areas do 
not overlap. It is unusual to see such extreme case of double staining as in Figure 8.11, 
but should be considered as a limitation. A more expected staining result is clearly either 
green or red cells.  
 
 
 
 
Figure 8.11 Above: RGB image of dead or damaged hFF cells. Red areas are nuclei and 
dotted, non-uniform green areas around the nuclei are the cytosols of cells. Below: Sep-
arate channels of the same image. It is evident from green channel (left) that the there 
are gaps exactly in those locations where nuclei are seen in the red channel (right).  Scale 
bar = 200 µm. 
 
Another setback of the algorithm was that the volume that is possible to be observed in 
hydrogel decreases with this method, as cells off the focus plane were filtered out. The 
extent of this happening depends on how the threshold values. A difficulty in counting 
cells automatically with Particle Count algorithm is finding the correct threshold values. 
Especially, determining values to filter out “false green” was challenging, because the 
green intensities of these cells were close to that of live cells. The threshold cannot be 
raised too much, because live cells that are slightly off focus but still visible (countable), 
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have lower intensity as well.  In addition, the hydrogels were autofluorescent (in green). 
The thicker the hydrogel is between the objective lens and cells, the more the hydrogel 
will decrease the intensity that is observed from the cells. Therefore, the needed threshold 
values can differ between images.  
 
8.2.6 Assessment of attachment and viability 
Attachment and survival of cells on top of control materials and gellan gum are presented 
in Figure 8.12. Attachment of cells on different materials was compared to 2D, which had 
a comparison value 1. Attachment on GG 1.5% SPD was significantly greater than on 
PM and 2D. Even though viability was high on PDSM, attachment on PDMS was low, 
as expected. Both attachment and viability of cells on top of PM were higher on than on 
uncoated well plate and PDMS.  
 
 
Figure 8.12 Attachment and viability of WI-38 cells on top of control materials and gellan 
gum. Error bars denote standard deviation. Number of analyzed images was n (2D, 
PDMS, PM) =8, n (GG) = 5. 
 
According to the assessed 3D samples, viability of cells encapsulated in PM was lower 
than in GG (Figure 8.13). Viability was also lower in PM than on 2D (but not necessarily 
statistically different). Although, the environment of cells on 2D is different than inside 
hydrogels, and therefore 2D can only be compared as a reference.  
 
It is noteworthy, that standard variation in these results was very high, especially in case 
of viability assessment on OnGel samples. Possibly bigger number of images per sample 
would make the results more reliable. In addition, it can be concluded that PuraMatrix® 
can be used as a positive control for attachment and viability. Using PDMS as a negative 
control of viability on top of materials is questionable, because viability was higher than 
on 2D uncoated well. 
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Figure 8.13 Viability of WI-38 cells encapsulated in PuraMatrix® (PM) and gellan gum 
(GG). 2D sample is shown as a reference. Number of analyzed images was n (2D and 
GG) = 6 and n (PM) = 9. 
 
Because of different layouts, viability of cells on top (Figure 8.12) and encapsulated in 
hydrogels (Figure 8.13) cannot be directly compared. In addition, viability of cells on 
samples was analyzed 5 hours after sample preparation, while viability of cells encapsu-
lated in samples was analyzed after 2 days. However, 2D samples can be compared be-
tween these two experiments, and it seems that cell viability after a few hours of culturing 
was nearly half of viability after 2 days. Also fluorescence images (Appendix 6) reveal 
that cells look healthier on 2D after longer culture time.  
8.2.7 Cell behavior  
Phase contrast images from 2D positive control showed that cells had a longitudinally 
spread out morphology before staining with Live/dead viability/toxicity kit. In images 
after staining, cells had retracted from this spread morphology and become more round. 
The retraction of cells increased over time, which was seen in three rounds of images 
taken with 70 min interval from the same location (two rounds after staining shown in 
Figure 8.14). Incubation time with Live/dead staining solution was 40 min and double 
concentration was used (0.10 µM EthD-1 and 0.20 µM Ca-AM solution). 
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B
 
Figure 8.14 Phase contrast images of WI-38 cells on uncoated well. Same cells were 
imaged before staining (A), after staining (B) and 70 minutes later (C). Images were 
taken with 10x magnification (upper row; close-up in lower row). 
This retraction of cells from their spread-out morphology was an interesting observation. 
Live/dead assay is an end-point analysis method, because the cells will eventually die 
after staining. However, cells should not die this fast, because the method detects cell 
viability and the incubation time was only 40 minutes. Staining with Live/dead kit was 
not used for morphological observations in this protocol, but spread out morphology in-
dicates cell attachment to material [41]. Attachment, in turn, is generally considered a 
parameter for testing biocompatibility. 
A B C 
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9. DISCUSSION AND FUTURE RECOMMENDA-
TIONS 
Several standards cover cytotoxicity and biocompatibility testing of materials or charac-
terization of hydrogels for use in biomedical applications. These standards, which were 
introduced in this thesis, offer a good knowledge base for testing cytocompatibility of 
hydrogels. However, most standards describe the methods only in a general level, and 
methods used in the literature are varying. This thesis aimed to provide detailed instruc-
tions for first-step cytocompatibility screening of hydrogels by using one of the available 
methods, namely Live/dead staining and imaging. This method was chosen because it is 
easy, inexpensive and fast, and hydrogels do not have to be destructed for the analysis. 
Unlike in standards ISO 10993-5 [14] and ASTM F813 [33], cells were cultured on and 
encapsulated in hydrogels instead of under the test  specimen. This layout represents bet-
ter the final application of hydrogels as a cell culture substrate. In addition, reasoning for 
choosing a representable cell line for each step of the protocol was provided, so that the 
protocol could be used to test hydrogels specifically for different cell types. 
 
For the first-step cytocompatibility screening protocol, a human fibroblast cell line WI-
38 was chosen, which is a natural, finite cell line with a long life time. Variation occurs 
to some extent always when biological substances are used in experiments, but this can 
be minimized by using cell lines. Even though especially immortalized cell lines offer 
reproducible cell culture models, choosing a finite cell line is beneficial in biomaterial 
research because transformation of cells can cause alterations in growth characteristics, 
such as loss of anchorage dependence and contact inhibition [6].  
  
In addition, using a human cell line was beneficial for two reasons. First, human fibro-
blasts have been found stabile [6], and second, the interviewed research groups of Bio-
MediTech institute study human cells in their final applications. Therefore, more repre-
sentable results can be obtained by using human cells from the first step on. Animal cells 
can be used in basic research, but results in their behaviour cannot be directly applied to 
human cells, and animal cells cannot be used in further clinical applications [78, p. 641].  
 
WI-38 cells did not spread when cultured on top or encapsulated in hydrogels. It must be 
remembered, however, that the morphology cells have when growing on a 2D surface, is 
most likely not what should be expected from morphology of a cell in 3D. In general, in 
3D environment human fibroblasts are spindle-shaped opposed to having flat morphology 
[60], and more natural morphology and behaviour is the aim with using 3D cell culture 
substrates.  
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The results in this experience showed round cells, and not yet even spindle-shaped cells. 
The culture time was quite short in this protocol, and in future experiment it is advised to 
increase the culture time. In addition, less elongated morphology and slower proliferation 
of cells grown in hydrogels compared to 2D has been previously shown [56], [60]. This 
is understandable, because the cells need to overcome impediments caused by the sur-
rounding hydrogel, which acts as a physical barrier. Several properties of hydrogels, such 
as stiffness and presence of biological cues, affect the morphology and proliferation of 
cells in hydrogels. [7] More alarming behaviour was seen on 2D, where cells became 
round after staining, and the reason for that is unclear.  
 
By culturing cells on top of hydrogels for few hours, attachment was primarily tested. At 
the same time, it was possible to calculate viability of cells on hydrogels as well. As 
discussed earlier (Chapters 6 and 7), attachment is analyzed after a short culture time, but 
for viability testing a longer culture time is usually needed. Therefore, it is not surprising 
that cells looked healthier and showed higher viability on 2D after longer culture time (48 
h). This comparison shows that if cell viability is analyzed on top of hydrogels, 5h culture 
time is most likely too short to reliably assess viability of cells, and instead similar culture 
time has to be used as with cells encapsulated in hydrogels. 
 
In addition, cells were often unevenly stained or cells had stained with both calcein and 
EthD-1. This made interpreting results difficult. Thus, the staining conditions with 
Live/dead cytotoxicity/viability kit should be further optimized. Another possible reason 
for the unclear appearance of cells may be in too low seeding density. Seeding densities 
under the recommended minimum of 2 × 104 cells / cm2 was used in some experiments, 
because cells are difficult to count in higher densities. If higher seeding densities will be 
used in the future, it is recommended to stain the nuclei of cells with DAPI simultaneously 
with calcein-AM and EthD-1. 
 
In future experiments, also other fluorometric or colorimetric analysing methods for via-
bility, could be tried, which allow reading with a microplate. This might be a faster ap-
proach for screening. The reagent should not cause too high background reading with 
hydrogels. It should be noted that many colorimetric and fluorometric assays are destruc-
tive, meaning that the hydrogel has to be broken down for analysis. In addition, these 
methods usually require a standard curve, and existing data on interpreting result are op-
timized for 2D cultures [9]. 
 
In the chosen analysis method for this protocol, imaging and image analysis were the 
challenges related to adjusting analysis methods from 2D to 3D culture. Due to the nature 
of the samples, encapsulated cells were located at different depths in 3D samples, as ex-
pected. Because of this, only few cells were in focus at one time. This was also true in 
case of OnGel samples because of large topological variation. Cells were also unevenly 
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distributed in the hydrogels leaving some areas emptier. Because of these reasons, infor-
mation retrieved from a single image was usually small.  
 
In addition, even though BioStation CT was the more suitable for imaging hydrogels than 
ApoTome and Cell-IQ, it had many limitations in imaging options and increasing the 
number of images taken per sample may be time-consuming. On the other hand, the re-
sults of attachment and viablilty assessment had large standard variations and to improve 
the reliability and statistical significance of the results, it is suggested that the number of 
images taken per sample would be as high as feasible. Because of several aspects that 
were optimized during development of this protocol, the number of repeated testing was 
low with the final experimental parameters and settings. Further repeated studies are 
therefore needed as well.  
 
The more automated analysis algorithms are found for analysing images and counting 
cells, the faster and more efficient the screening protocol will be. Therefore, the current 
algorithm presented in this thesis, could be further improved. In addition, there are num-
ber of other software aside FiJi that could be used for image analysis. For example, CL-
Quant is a software produced by Nikon, which is especially designed to analyse images 
taken with BioStation CT. It is based on machine learning, and therefore it can be taught 
which cells should be counted. FiJi was chosen over CL-Quant in this thesis because FiJi 
is a commonly used open source software. 
 
Another reason to analyse images with FiJi is that objective parameters for counting cells 
(based on size and intensity) can be given in FiJi. For example, teaching a machine learn-
ing based program to count encapsulated cells in hydrogel would require choosing cells 
subjectively in different depths. In FiJi, on the other hand, the same values can be used to 
all images. However, the more cells are processed with a machine learning program, the 
more accurate the recognizing and counting becomes. Since FiJi needed much work to 
find correct steps and values, and writing macros for counting cells, the amount of work 
to create an accurate counting algorithm in CL-Quant may not exceed the effort of creat-
ing an algorithm in FiJi. In addition, because CL-Quant is a program designed especially 
for BioStation CT images, even observing images (in RGB and different points) may be 
easier. Therefore, it is worthwhile to consider using CL-Quant instead of FiJi.   
 
A negative control could be further searched for. PDMS was a successful negative control 
only for attachment. As a non-cytotoxic material, it does not cause a decrease in viability. 
In addition, because cells cannot be encapsulated inside PDMS, and therefore the control 
would not be similar to test samples, it was not used as a control in case of testing viability 
inside hydrogels. PuraMatrix® showed good results in viability and attachment, as ex-
pected. However, PuraMatrix® was difficult to handle and hydrogels were very inhomog-
enous in thickness throughout the sample. Therefore, finding a better 3D positive control 
could also be considered. 
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The protocol presented as a result of this thesis has been already used in hydrogel cyto-
compatibility screening in BioMediTech (Tampere University of Technology). In future 
experiments, optimizing the cytocompatibility screening protocol should be continued 
with other parts suggested in Figure 8.1 (parts 1 C-D, 2 and 3). These include studies with 
more specific cells of each cell type (cells suggested in Table 7.2) and optimizing testing 
of proliferation and morphology of cells, and function of more specific cells. 
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10. CONCLUSIONS  
Based on literature and interview, a three-phase cytocomptibilty testing protocol was pro-
posed, starting with a general cell line and ending with the intended cell type for the final 
application of the tested hydrogel. Most interviewed research groups shared at least re-
quirements of using a human cell line and testing of viability of cells for the cytocompat-
ibility screening of hydrogels. Attachment and viability screening with a general, fibro-
blast cell line, was optimized in practice. The final protocol, i.e. instructions for attach-
ment and viability screening, is presented in Appendix 3. 
 
A commercial human embryonic fibroblast cell line WI-38 was cultured on the surface 
and encapsulated in 3D macroscopic hydrogels. This finite cell line filled the set criteria 
in theory, but based in these experiments it is unclear whether the stability of WI-38 cells 
was sufficient for this protocol. Cell density, culture time, and staining concentrations 
should be further optimized for WI-38 cells. 
 
Nikon BioStation CT proved to be the most suitable imaging system between the tested 
systems and imaging settings were found for attachment and viability testing. However, 
because BioStation CT had several limitations, it was not an optimal imaging system for 
screening three-dimensional hydrogels. Thus, it is suggested to continue the search for 
optimal imaging system. Maximum focusing range was achieved by using Greiner Bio-
one CELLSTAR® 48-well plate, which has a lower bottom than multiwall plates of some 
other manufacturers. Hydrogels with volume of up to 250 µl were entirely visible with 
this well plate, corresponding to effective working distance of 1600 µm. 
 
Several algorithms and parameter values were tested in FiJi software for counting cells. 
A macro was written for one part of the image analysis, which made the analysis more 
efficient. However, with the used parameter values, Particle Count algorithm was not 
accurate enough to count live and dead cell from fluorescence images. Cells were counted 
manually for assessing attachment and viability of cells on hydrogels and viability of cells 
encapsulated inside hydrogels.  
 
As expected, PuraMatrix® and gellan gum were cytocompatible. Attachment and viability 
of cells on top of PuraMatrix® and gellan gum were better than on 2D. Viability of cells 
inside hydrogels did not significantly differ from 2D. Attachment of cells on PDMS was 
significantly smaller, as expected, but PDMS could not be used as a negative control in 
viability testing. 
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APPENDIX 1 
 
INTERVIEW QUESTIONS FOR SELECTING A CELL LINE AND ANALYZING 
METHOD OF CELLS 
 
Generally, a cell line chosen for this protocol should fill the following criteria: 
1. commonly used and readily available, not too expensive 
2. well characterized and standardized (identity, purity, safety) 
3. relatively easy to culture, yet sensitive enough not to grow in an unsatisfactory 
hydrogel 
4. robust, stabile; as repeatable growth as possible  
5. growth rate high enough so that it can be used in short time screening  
6. adherent i.e. anchorage dependent cell line (not growing in solution, such as some 
hematopoietic, tumor and hybridoma cells). 
 
Cell line vs. used cells, criteria 
 
1. In addition to general criteria, what are other criteria for selecting the cell line re-
lating to origin of the cell (see below)? 
a. Species: should the cell be human or animal derived / does the species have any 
significance? 
b. Age: should the cell be derived from a patient / animal of certain age (embryo / 
fetal / adult / iPS cell?) 
c. Would it be better to use a finite or continuous cell line? 
d. Immortal cells might have a drawback of having other transformations affecting 
the phenotype. Are transformed cells (for example, cells obtained with human 
telomerase reverse transcriptase (hTERT) transformation) representative in this 
case? How about tumor cells? 
e. According to one source [17] the biggest advantage of using cell culture is the 
consistency and reproducibility of results that can be obtained from using clonal 
cells. On the other hand, a cell strain often acquires additional genetic changes 
subsequent to the initiation of the parent line [17]. Should clones be used? 
2. Should the cells be pre-adapted to a certain growth medium or serum-free medium? 
Should serum be used (batch variation versus cost etc.)? Serum might disturb uniform 
gelation during gelation time, however after that serum can be present.  
 
3.  Which cell should the chosen cell line represent? Which cell line mimics the best cells 
that you use yourself? 
 
4.  Which cell line(s) that meets the above criteria would you recommend for this proto-
col? Which properties, advantages, and disadvantages it has? 
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Hydrogels with cells 
 
5. In the future, in which applications you could imagine needing hydrogels in cell 
culture?  
 
6. How should the cell-hydrogel combination be arranged; cells on top, under or in-
side the hydrogel? 
 
Cell culturing and analyzing methods 
 
7.  Which amount of parallel samples is reliable? Is it enough to test with one cell 
line only, or should there be several cell lines?  
 
8. What (gel) would you use as a positive and / or negative control?  
 
9. Does the recommended cell line normally need a certain molecule to attach to the 
substrate (e.g. laminin for neurons)?  
 
10. How long is the shortest possible culturing time in order to observe reactions to-
ward a new material? 
 
11. Which end-point analyzing method would you use? Is there a method you would 
use already during culturing to observe cells? 
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APPENDIX 2 (1/3) Interview results 
 
  NEURO CORNEA RETINA HEART MESENCHYMAL STEM CELL 
 CELLS           
Species human human human not significant human 
Age other than adult (blastoma can 
be from a child) 
if cell line, not signifi-
cant 
if cell line, not signifi-
cant 
not significant adult ok, young better 
Finite / continu-
ous 
Continuous line better;  if  finite, 
proliferating enough for banking 
continuous continuous Continuous line better, but 
they do not beat.  
Fibroblasts if finite. 
continuous 
Transformed  yes, as long as negative control 
found 
yes  yes yes no 
Tumor  yes, as long as negative control 
found 
no no - yes 
Clone not necessary not recommended not recommended not necessary not necessary 
Should represent any young CNS cell corneal epithelial (CE) 
cell 
retinal pigment epithe-
lial (RPE) cell 
differentiated cardiomyo-
cyte 
mesenchymal stem cell 
(Mimicking) cells 
in use 
iPS derived neurons,  
hNP1 (hESC derived neurons)  
hiPS derived CE cells, 
human primary CE 
cells, 
HCE-T 
hiPS derived RPE cells, 
human primary RPE 
cells, ARPE-19 
primary rat cardiomyocytes,  
END2,  
PA6 
mesenchymal stem cells,  
sarcomas,  
fibroblasts 
Recommended 
cells 
SH-SY5Y (neuroblastoma),  
hNP1 (hESC derived progenitor), 
iCell (hiPS derived neuron),  
fetal neural progenitors / neural 
stem cells   
HCE-T ARPE-19 Fibroblasts,  
continuous cardiomyocyte 
fibroblasts,  
SAOS-2 (osteosarcoma), 
chondrosarcomas 
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APPENDIX 2 (2/3) Interview results 
 
  NEURO CORNEA RETINA HEART MESENCHYMAL STEM CELL 
SUBSTRATE      
Applications 3D cell culture, disease 
model, drug and toxicity 
testing. As a scaffold in 
transplantation therapy. 
to mimic the structure of 
stroma 
thin biomimetic substrate 3D cell culture, drug and 
toxicity testing. As a scaffold 
in heart patch. 
3D cell culture 
Arrangement of 
cells 
on top, inside on top only on top only on top, inside inside  
Positive control 3D: Puramatrix®.  
2D: laminin coated well. 
3D: Hydrogel not in use; 
try collagen.  
2D: uncoated well. 
3D: Hydrogel not in use.  
2D: uncoated well. 
3D: Puramatrix®, Matrigel®. 
2D: gelatin coating 
Cartilage: collagen.  
Soft tissue: Matrigel®, Tis-
sel.  
2D: Uncoated well 
Negative control 3D: Hydrogel not in use 
(try unmodified PEG, chi-
tosan, and unmodified cel-
lulose).   
2D: uncoated well. 
3D: hydrogel not in use; 
try HA-PVA.  
 2D: Uncoated well  
Molecule for  
attachment 
laminin not with HCE-T not with ARPE-19 gelatin, collagen (for cardio-
myocytes) 
no 
Serum serum-free preferred in clinical use no serum; 
cell lines with serum 
in clinical use no serum; 
cell lines with serum 
serum-replacement (for car-
diomyocytes) 
serum is normally used 
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APPENDIX 2 (3/3) Interview results 
 
  NEURO CORNEA RETINA HEART MESENCHYMAL STEM CELL 
METHODS           
Parallels 3-5 3  3  3-5 5 (with which 3 repetitions 
first), later 3 parallels 
Culture 
time 
2 weeks 1 week 3-4 days (to detect the formation 
of mature RPE monolayer 28 to 
42d) 
1 week with fibroblasts 2 weeks  
(differentiation test 4 weeks) 
Analyzing 
methods 
a) Live/dead  
b) microscopy 
c) immunostaining  
d) RNA / protein  
isolation 
  
a) Live/dead  
b) Microscopy and Presto blue  
proliferation assay  
c) Immunofluorescence  
staining  
d) (transepithelial resistance,  
gene expression) 
a) Live/dead  
b) Microscopy and Presto blue 
proliferation assay  
c) Immunofluorescence staining  
d) (transepithelial resistance, 
gene expression) 
a) Live/dead,  
b) number of cells /  
nuclei  
c) immunostaining  
d) immunostaining of 
KI67  
e) time-lapse monitoring 
a) microscopy and imaging 
(during growth)  
b) enzyme activity,  
immunochemical methods, 
PCR 
To observe a) viability 
b) morphology 
c) neuronal markers 
(identification), 
differentiation,  
apoptosis,  
migrational markers 
d) proliferation,  
genotype, phenotype 
a) viability 
b) proliferation  
c) morphology  
d) (functionality) 
a) viability 
b) proliferation 
c) morphology  
d) (functionality) 
a) viability  
b) proliferation  
c) morphology  
d) cell division  
e) migration (+ attach-
ment) 
a) morphology, attachment 
b) proliferation (differentia-
tion) 
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APPENDIX 3 
 
PROTOCOL FOR TESTING CELL ATTACHMENT AND VIABILITY IN  
HYDROGELS  
 
Attachment and viability testing share common instructions in most steps of this protocol. 
Steps that differ between those tests are specified in the protocol, otherwise the same steps 
are followed.  
 
Attachment of cells is tested by culturing cells on hydrogels (named here OnGel samples). 
Viability of cells can be tested both encapsulated in hydrogels (3D samples) or on top of 
hydrogels (OnGel samples). 2D denotes uncoated well plate in this protocol. Hydrogels 
of 200 – 250 µl final volume can be assessed with this protocol. Volumes and concentra-
tions for sample preparation are calculated here for 200 µl hydrogels. 
 
The protocol includes the following main steps: 
1. Preparation of materials and cell culture 
2. Sample preparation 
3. Phase contrast imaging in BioStation CT 
4. Live/dead staining 
5. Phase contrast and Fluorescence imaging in BioStation CT 
6. Image Analysis in FiJi software 
7.  Quantitative analysis 
 
1. Preparation of cells and materials before experiment 
1.1 Grow WI-38 cells at least one week after thawing. WI-38 cells are subcultured 
twice a week with 1:2 ratio (or with seeding density of 2-4×104 cells / cm2).  
 Medium for WI-38 cells (“WI-38 medium”) contains DMEM-F12 me-
dium supplemented with 10% FBS, 1.25% Glutamax, and 0.5% Penicil-
lin/Streptomycin.  
1.2 Prepare stock solutions and dilutions of hydrogels and crosslinkers that will be 
tested. Sterilize unsterile solutions by sterile filtering, if applicable. 
1.3 For attachment test: prepare poly(dimethylsiloxane) (PDMS) discs with around 1 
mm thickness or smaller, and 8.5 mm diameter. (Diameter has to be smaller than 
the diameter of 48-well). Sterilize PDMS discs by autoclaving in 121 °C for 15 
min. 
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2. Sample preparation 
2.1 Warm up WI-38 medium and DMEM –F12 medium to 37 °C.  
2.2 Prepare cell suspensions. 
 Wash a T75 bottle of WI-38 cells two times with 10 ml DPBS. Detach 
cells with 2.5 ml trypsin, let it affect for 5-10 min. Stop trypsinization with 
7.5 ml WI-38 medium (or DMEM-F12 medium if unsupplemented me-
dium is needed for sample preparation).  
 Count cells and prepare required concentrations of cell suspensions (see 
Table 1). Note that for encapsulated PuraMatrix® (PM) samples, cells are 
suspended in 10% sucrose solution. Cells for test samples may be diluted 
to media according to their respective instructions. 
 Keep the temperature as close to 37 °C as possible while working at all 
times, and allow sufficient change of gases for cells (if needed, leave the 
cap untightened).  
 
Table 1 Required concentrations of cell suspension, which are prepared in step 2.2. Pre-
sented volumes of the cell suspensions are needed to prepare samples with indicated final 
cell densities (step 2.3). Values for encapsulated (3D) sample layout is given only for PM; 
concentration and volume of cell suspension for test hydrogel are prepared according to 
their respective instructions, so that the final cell density would be equal to cell density 
in PM. Area of CELLSTAR® 48 well is 1.13 cm2 and volume of hydrogels is 200 µl. 
Sample layout Concentration 
(cells / ml)   
Volume 
(µl) 
Final cell density 
(cells / cm2) (cells / µl of gel) 
2D, PDMS, OnGel 45200 - 67800 500 2-3 × 104 -  
3D (PM) 1.2 × 106 100 -  600  
 
2.3 Prepare samples and controls into CELLSTAR® 48-well plate (Greiner Bio-one). 
In all tests, leave one row of wells on each side of the well plate empty (for better 
imaging results). Prepare at least 3 replicates (parallel samples) of all samples and 
controls.  
 For testing attachment, PDMS is used as the negative control. Positive 
controls are uncoated well (2D) and PM (OnGel layout, cells on top). 
 For testing viability of cells on top of hydrogel, 2D is used as a reference 
and PM (OnGel layout, cells on top of hydrogel) is used as positive con-
trol. 
 For testing viability of cells encapsulated in hydrogel, 2D is used as a ref-
erence and PM (3D layout, cells encapsulated in hydrogel) is used as pos-
itive control.  
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Attachment test  
a) PDMS discs are simply placed in the bottom of the wells. (Handle PDMS 
discs with tweezers at all times, do not touch PDMS discs with gloves, 
because they leave a stain on PDMS.) Transfer 500 µl of cell suspension 
in 2D control wells and on PDMS discs so that cell density on 2D and 
PDMS is 2-3 × 104 cells/cm2. 
b) Prepare PM hydrogels with final volume of 200 µl according to PuraMa-
trix® instructions. In brief, transfer 200 µl of PM stock solution (1 mg/ml) 
into a well and, very carefully, add 400 µl of WI-38 medium for crosslink-
ing. The medium needs to be added extremely carefully and slowly along 
the side of the well. Refresh medium twice within one hour. 
c) Prepare test hydrogels according to their respective instructions (for ex-
ample, refer to Chapter 8.1.1.2.). Prepare all hydrogel samples with final 
volume of 200 µl. 
d) After sufficient crosslinking, add 500 µl of cell suspension on the hydro-
gels (PM and test samples). Final cell density on all samples should be 2-
3 × 104 cells/cm2. 
e) Add water to empty wells. 
f) Leave the plate in incubator or in BioStation CT for a few hours (minimum 
2 h).  
 
Viability test of cells on top of hydrogel 
Prepare samples and controls according to instructions for attachment test, except 
for PDMS, which is not used, and culture cells in incubator for 1-3 days after 
sample preparation. 
 
Viability test of cells encapsulated in hydrogel 
a) PDMS discs are simply placed on the bottom of the wells (do not touch 
PDMS discs with gloves). Transfer 500 µl of cell suspension in 2D control 
wells and on PDMS discs so that cell density on 2D and PDMS is 2-3 × 
104 cells/cm2. 
b) Prepare all hydrogel samples with final volume of 200 µl (for example, 
refer to Chapter 8.1.1.2.). Cell density in encapsulated samples (PM and 
test hydrogels) should be 600 cells/µl of hydrogel.  
c) Prepare PM hydrogels according to PuraMatrix® instructions. In brief, mix 
100 µl of cell suspension (cells in 10% sucrose) and 100 µl of PM stock 
solution (1 mg/ml). Transfer the mixture (200 µl) into a well and, very 
carefully, add 400 - 500 µl of WI-38 medium for crosslinking. The me-
dium needs to be added extremely carefully and slowly along the side of 
the well. Refresh medium twice within one hour. 
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d) Encapsulate cells to test hydrogels according to their respective instruc-
tions. Add 400 - 500 µl of fresh WI-38 medium on the samples after suf-
ficient crosslinking.  
e) Add water to empty wells. 
f) Leave the plate in incubator for 1-3 days (or place in BioStation for time-
lapse imaging). If a longer culture time is desired, medium has to be re-
freshed every three days. 
 
2. Phase contrast imaging (BioStation CT) 
Place the well plate to BioStation CT half an hour before start of imaging to allow tem-
perature equalize between well plate and BioStation CT. Condensation droplets will form 
under the well plate, and they disturb imaging, before the temperature has equalized. Use 
“Standard 48 well plate” as the well plate option. 
 
The same imaging points are imaged with phase contrast microscope (Ph channel) before 
staining, and with Ph and fluorescence microscope (FL channels) after staining with 
Live/dead staining solution. Imaging with Ph channel before staining is optional in terms 
of the attachment and viability tests presented here, but this step makes setting imaging 
points faster after the staining and images may be useful for qualitative analysis.  
 
Imaging points are set the same way for both attachment and viability tests; settings are 
dependent only on sample layout. Use the settings described in Table 2 for imaging sam-
ples and controls with phase contrast channel. Autofocus may be used with hydrogel sam-
ples, but it is unreliable with these samples. In that case, check images taken with autofo-
cus in the beginning of the test to ensure images are focused to cells (inside or on the 
sample). 
 
Another option to settings in Table 2 would be to image 2D, PDMS and 3D sample with 
Full Scan ja Tiling functions (see Chapter 8.2.4). Full Scan gives more images at the same 
time per one Z level, but all coordinates cannot be saved for a new experiment and one Z 
level is imaged at one time. Therefore, the Full Scan imaging is useful after staining. 
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Table 2 Settings for imaging points in different sample layouts. *Autofocus may be feasi-
ble, if sample is homogenous and surface is even. 
Setting 2D PDMS OnGel 3D 
Observation points 5 default custom 
(Figure 1) 
custom 
(Figure 1) 
custom 
(Figure 1 and 
Table 4) 
Channel Ph Ph Ph Ph 
Magnification 10x 10x 10x 10x 
Focusing autofocus custom custom* custom * 
Copying points automatically 
set, no need 
no no yes 
Z stack no no no no 
 
When custom points are used, set the imaging points in samples by using the well plate 
map in Figure 1. The map is helpful in navigating in the samples by moving with arrows: 
each square corresponds to the area seen in the control panel of BioStation CT in the live 
mode (10x magnification).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Images that are obtained from the points marked in the well map (Figure 1) are named 
with x, y coordinates listed in Table 3. Other imaging points can be used, and especially 
for 3D samples the number of custom points is recommended to be larger than 5. How-
ever, points should be set to the colored area marked in Figure 1. 
 
 
                             
                              
                               
                              
                               
        2          
                  
      5  1  4        
                  
        3          
                               
                               
                              
                              
                               
Figure 1.  Well map for setting custom points. Each square corresponds to the area of 
well visible in "Live mode" at each time with 10x magnification.  
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Table 3 Coordinates of imaging points in Figure 1, according to their distance from the 
center point of well. The imaging points are named in this way in resulting image files. 
In BioStation CT, these coordinates are not visible, but the distances are equal to the 
coordinates shown in BioStation CT. 
 Coordinates (picture files) 
Point x y 
1 000000 000000 
2 000000 001520 
3 000000 -001520 
4 001520 000000 
5 -003040 000000 
 
Z values for custom points in Figure 1 can be chosen according to Table 4, according to 
the respective sample volume. These Z coordinates are given as examples, based on the 
average Z values on the surface of gellan gum gels in earlier experiments. Imaging points 
are set lower than those values, not to image above hydrogel samples. However, other Z 
values can be used if needed. 
 
Table 4 Examples of Z values that can be set for points in 200 µl or 250 µl samples. 
Point 200 µl 250 µl 
1-2 3200 µm 3400 µm 
3-5 3400 µm 3700 µm 
 
Z = 3150 µm is the estimated average Z coordinate for well bottom in the middle of the 
well. Therefore, Z coordinates can be safely set to two levels, Z1 = 3200 µm and Z2 = 
3400 in case of 200 µl hydrogel, and Z1 = 3200 µm and Z2 = 3600 in case of 250 µl 
hydrogel.  
 
Note: BioStation changes ΔZ = 0 µm corresponding to Z = 3500 µm when returning from 
New experiment mode into Live observation mode. Therefore, it is more useful to set 
points according to Z value, instead of using ΔZ. 
 
Before scheduling the experiment, select the option Holder  Save to save the set op-
tions. Schedule the experiment to obtain phase contrast images. 
3. Live/dead staining 
Prepare a solution from LIVE/DEAD® cytotoxicity/viability kit (ThermoFisher Scien-
tific) by mixing 5 µl EthD-1 (stock 2 mM, final 0.1 µM) and 2 µl calcein-AM (stock 1 
mM, final 0.2 µM) into 10 ml PBS, 37 °C (work protected from light). Aspirate medium 
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from wells very carefully, avoiding disruption of hydrogels. Add 500 µl of staining solu-
tion to each well. Incubate in BioStation CT (37 °C) for 30 - 45 min before imaging.  
4. Fluorescence imaging 
Check that condensation droplets under the well plate have disappeared, as they disturb 
or even prevent imaging. Droplets can be wiped of gently with tissue paper, if incubation 
time tends to become too long. Observe cells with fluorescence channels in live mode to 
determine correct excitation times for each channel. To make the next step faster, the 
chosen excitation times can be set as personal options in main menu. 
 
In New experiment mode, use either “Previous setting” or load the previously saved 
holder to retrieve previously set imaging points and their imaging settings. Now, add flu-
orescence channels to settings of each well (Ch2 for live and Ch4 for dead cells in our 
laboratory, filter cubes can be changed depending on equipment). In addition, see that the 
excitation times are correct for each sample. Schedule the experiment for obtaining phase 
contrast and fluorescence images.  
5. Image Analysis in FiJi software 
Analyze fluorescence images obtained in the previous step with ImageJ software, FiJi 
distribution. Use a macro Smart_J_worker (Appendix 5) to open and process images (all 
coordinates from one sample, one magnification, and one time point). Count the numbers 
of live cells (Li) and dead cells (Di) in each fluorescence image. Green cells are live and 
red cells are dead. If there are cells stained both with green and red stains, count them as 
dead cells.  
6. Quantitative analysis 
Numbers of live cells (Li) and dead cells (Di) in each image that were obtained in step 6 
are used here for calculating attachment and viability. For each sample, calculate the av-
erage numbers of live cells and dead cells in an image with equations 1 and 2. In one 
sample, the average number of live cells in an image is 
  
?̅? =
1
𝑛
∑ 𝐿𝑖
𝑛
𝑖=1
 ,                                                                                                     (1) 
 
and the average number of dead cells in an image is 
 
?̅? =
1
𝑛
∑ 𝐷𝑖
𝑛
𝑖=1
 ,                                                                                                     (2) 
 
where i = index of the image and n = number of images analyzed from the sample type. 
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Assessment of attachment 
 
Attachment of cells to test material is compared to attachment on uncoated well plate (2D 
positive control). Attachment is calculated according to equation (3). The average number 
of cells attached in one sample is represented by the average number of cells per image 
in the sample (?̅? for live cell; ?̅? for dead cells; and  (𝐿 + 𝐷)̅̅ ̅̅ ̅̅ ̅̅ ̅̅   for all cells). When s denotes 
sample and 2D denotes 2D positive control, attachment on a sample is: 
 
𝐴𝑡𝑡𝑎𝑐ℎ𝑚𝑒𝑛𝑡𝑠 =
𝑐𝑒𝑙𝑙𝑠 𝑜𝑛 𝑠𝑎𝑚𝑝𝑙𝑒 
 𝑐𝑒𝑙𝑙𝑠 𝑜𝑛 2𝐷
=
𝑎𝑣𝑒𝑟𝑎𝑔𝑒 (𝑐𝑒𝑙𝑙𝑠 𝑝𝑒𝑟 𝑖𝑚𝑎𝑔𝑒 𝑜𝑛 𝑠𝑎𝑚𝑝𝑙𝑒)
𝑎𝑣𝑒𝑟𝑔𝑎𝑒 (𝑐𝑒𝑙𝑙𝑠 𝑝𝑒𝑟 𝑖𝑚𝑎𝑔𝑒 𝑜𝑛 2𝐷)
               
=
(L + D)̅̅ ̅̅ ̅̅ ̅̅ ̅s
(L + D)̅̅ ̅̅ ̅̅ ̅̅ ̅2D
=
L̅𝑠 + D̅𝑠
L̅2𝐷 + D̅2𝐷
                                                                           (3) 
 
 
Using attachment values calculated for each sample, calculate the average attachment and 
standard deviation for each material. Uncoated well plate (2D positive control) has a com-
parison value of 1. 
 
Assessment of viability 
 
Viability of cells (both in 3D samples and OnGel samples) is calculated by dividing the 
total number of live cells with total number of all cells (dead and live) in a sample. The 
number of analyzed images is the same for both numbers, and viability can be calculated 
with average numbers of cells (live or all) per image. (This way same numbers can be 
used as above for attachment.) The viability is calculated for each sample according to 
equation (4). 
 
𝑉𝑖𝑎𝑏𝑖𝑙𝑖𝑡𝑦𝑠 =
(𝑙𝑖𝑣𝑒 𝑐𝑒𝑙𝑙𝑠)𝑠
(𝑙𝑖𝑣𝑒 𝑐𝑒𝑙𝑙𝑠 + 𝑑𝑒𝑎𝑑 𝑐𝑒𝑙𝑙𝑠)𝑠
                                                                        
=  
∑ 𝐿𝑖
𝑛
𝑖=1  
∑ (𝐷𝑖 + 𝐿𝑖)
𝑛
𝑖=1
 =  
1
𝑛
∑ 𝐿𝑖
𝑛
𝑖=1
1
𝑛
∑ 𝐷𝑖
𝑛
𝑖=1 +  
1
𝑛
∑ 𝐿𝑖
𝑛
𝑖=1
  =  
?̅?
?̅? +  ?̅?
                 (4) 
 
Using viabilities of each sample, calculate average viability for each material and their 
standard deviations. The viability of cells in tested hydrogel is compared to that of cells 
in 3D positive control, PuraMatrix®.  
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APPENDIX 4 
 
PARTICLE COUNT ALGORITHM FOR FIJI 
 
Before counting cells with this algorithm (or after step 1), it is advised to estimate the 
needed threshold values for green and red channel and the size of cells that will be 
counted. (Refer to Chapter 8.1.4.) 
 
1. Open images and create RGB stack 
a. Use a macro Smart_J_worker (Appendix 5) to open images (all coordi-
nates from one sample, one magnification and one time point). 
OR 
b. If merged RGB images have been saved already earlier (by using 
Smart_J_worker, for example) select File / Import / Image Sequence. Se-
lect one image in the folder where all imaged you want to analyze are 
saved. With default settings, all images in the folder will be opened. 
OR 
c. For taking this step manually (not recommended) choose for each individ-
ual points: 
i. Open images, green and read channel: File / Open… 
ii. Merge the channels: Image -> Color -> Merge Channels. 
iii. Choose the correct file for each color. Untick “create a composite”. 
One RGB type image has been formed.  
iv. Create an RGB stack: Image -> Type -> RGB Stack. A stack of 
three images is formed, in 8-bit format. Save the file and close. 
Repeat for all points in the sample and continue by importing all 
RGB stacks.  
2. Separate into stacks of channels 
a. Select Image / Color / Separate channels. This will create 3 stacks, one for 
each channel. 
b. Close the stack of Blue channel, it will not be analyzed. 
3. Adjust threshold 
a. For each stack, the threshold is set separately (allows choosing same or 
different threshold values). Choose one stack at a time, and select Im-
age/Adjust/Threshold. For example: 
i. threshold when analyzing red channel: 100-225,  
ii. threshold when analyzing green channel: 130-225 
iii. Method: default, color: B&W 
iv. Tick “dark background” and “stack histogram”  
v. Select “Apply” 
b. A new window opens for converting stack to Binary. Choose the following 
settings. 
i. Method: Default 
ii. Background: Dark 
iii. Other boxes not selected (If it is preferred to check that thresholds 
were set correctly, tick “List Thresholds”.)  
c. Now the stack has been converted to binary masks, where the images have 
only values 0 (background) or 255 (cells).  
d. Repeat adjusting threshold (step 3) to the second channel. 
 92 
4. (Optional step: Separate cells that are together  
a. Select Process/Binary/Watershed.  
i. Use default settings  
b. Watershed makes 1 px line between areas that FiJi considers two different 
particles.) 
5. Count particles 
a. Select one stack of channels at a time and use the Analyze Particles plugin: 
Analyze / Analyze particles. Settings: 
i. Size: for example, 40 px2 – infinity  
ii. Circularity: 0.00 – 1 (1 being a perfect circle) 
iii. Show: outlines 
iv. Tick: Display results, Clear results, Summarize, Exclude on Edges 
v. Untick: Add to Manager, Include holes, Record starts, In situ Show 
b. This step will produce a Summary window which shows the number of 
particles counted in the stack (either green or red channel). The Summary 
table can be saved or values can be copied for further calculations. 
c. Repeat step 5 to the stack of second channel. 
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APPENDIX 5 
 
MACRO FOR OPENING IMAGES AND MERGING CHANNELS IN FIJI 
 
BioStation CT has a very intricate way of dividing images into folders. This is very help-
ful for knowing the origin of the image, but screening pictures with FiJi (and manually) 
becomes slow because of this, as each image that was taken was located in individual 
folders behind a long path. A macro, “Smart_J_worker”, was written to more efficiently 
open images in FiJi from their respective folders and to merge the green and red channels. 
This macro was written by MSc Boris Kashentsev. 
 
The macro opens all images from one sample, that were desired to analyse at one time 
(Figure below):  
 all coordinates imaged with the same magnification (and fluorescent channels) 
 one time point of experiment 
 one time point of imaging round 
 both green and red channels.  
 
 
Figure: Distribution of images to folders after downloading from BioStation CT. The 
macro for FiJi opens images (.pgn) at the same time from: one sample, all coordinates 
imaged with the same magnification and fluorescent channels, one time point of experi-
ment, one time point of imaging round, from both green and red channels. The macro 
also merges the correct green and red channels and makes an RGB stack. 
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The macro merges the correct green and red channels and makes a stack of these RGB 
format images (all coordinates in one stack). The images can be automatically saved, in 
which case a new folder is created for the resulting images. The macro also enables open-
ing all imaging rounds at a time. 
 
The code of the macro can be saved as a .txt file and used for image analysis in FiJi by 
selecting Plugins/Macros/Run. Note that before using the macro, a black image is needed 
as the blue channel (because RGB image is formed). The black image should be 
1000x1000 pixel, named “blue.png” saved in the folder named in the code row 114 (for 
example, "C:\\pictures”). The macro asks for the location of images that will be analyzed.  
The code of the macro is below. 
1 
 
3 
 
5 
 
7 
 
9 
 
11 
 
13 
 
15 
 
17 
 
19 
 
21 
 
23 
 
25 
 
27 
 
29 
 
31 
 
33 
 
35 
 
37 
 
39 
 
41 
 
dir = getDirectory("Choose the channel folder containing one of the 
images you want to process."); 
 
dirComponents = split (dir, "\\"); 
 
Dialog.create("Smart Choice"); 
Dialog.addRadioButtonGroup("Choose the folder of current coordinate:", 
    dirComponents, 
    dirComponents.length,  
    1,  
    dirComponents[0]); 
Dialog.addRadioButtonGroup("Choose the folder of the imaging round (time 
stamp):", 
    dirComponents,  
    dirComponents.length,  
    1,  
    dirComponents[0]); 
Dialog.addCheckbox("Save to folder", false); 
Dialog.addCheckbox("Analyze all time points",false); 
Dialog.show(); 
 
coordinatesDir = Dialog.getRadioButton; 
timeStamp = Dialog.getRadioButton; 
toSave = Dialog.getCheckbox(); 
toAllRoundTimes = Dialog.getCheckbox(); 
 
for(i = 0; i < dirComponents.length; i++){ 
    if(dirComponents[i] == coordinatesDir){ 
        indexOfCoord = i; 
    } 
    if(dirComponents[i] == timeStamp) { 
        indexOfTime = i; 
    } 
} 
 
coordinatesDirComponents = split(coordinatesDir, "-"); 
magnification = coordinatesDirComponents[coordinatesDirCompo-
nents.length-2]; 
 
dirBeforeCoor = dirComponents[0]; 
for(i=1; i<indexOfCoord; i++){ 
    dirBeforeCoor = dirBeforeCoor + "\\" + dirComponents[i]; 
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43 
 
45 
 
47 
 
49 
 
51 
 
53 
 
55 
 
57 
 
59 
 
61 
 
63 
 
65 
 
67 
 
69 
 
71 
 
73 
 
75 
 
77 
 
79 
 
81 
 
83 
 
85 
 
87 
 
89 
 
91 
 
93 
 
95 
 
97 
 
99 
 
101 
} 
 
listOfDir = getFileList(dirBeforeCoor); 
index=0; 
for(i = 0; i < listOfDir.length; i++){ 
    if(indexOf(listOfDir[i],"-"+magnification+"-")!=-1 && indexOf(lis-
tOfDir[i],"-FL")!=-1){ 
        if(index == 0){ 
            listOfNeededDir = listOfDir[i]; 
            index = 1; 
        } else { 
            listOfNeededDir = Array.concat(listOfNeededDir, lis-
tOfDir[i]); 
        } 
    } 
} 
 
dirBeforeTime = ""; 
for(i = indexOfCoord + 1; i < indexOfTime; i++){ 
    if (dirBeforeTime == "") 
        dirBeforeTime = dirComponents[i]; 
    else 
        dirBeforeTime = dirBeforeTime + "\\" + dirComponents[i]; 
} 
 
//print(dirBeforeTime); 
 
if (dirBeforeTime == "") 
    listOfRoundDir = getFileList(dirBeforeCoor + "\\" + coordi-
natesDir); 
else 
    listOfRoundDir = getFileList(dirBeforeCoor + "\\" + coordinatesDir 
+ "\\" + dirBeforeTime); 
 
index = 0; 
for(i = 0; i < listOfRoundDir.length; i++){ 
    //print(listOfRoundDir[i]); 
    if (indexOf(listOfRoundDir[i], "\/") != -1){ 
        //print("Went through: " + listOfRoundDir[i] + " index: " +index 
); 
        myArray = split(listOfRoundDir[i], "\/"); 
        if(index == 0) { 
            correctList = myArray[0]; 
            index = 1; 
        } 
        else 
            correctList = Array.concat(correctList, myArray[0]); 
    } 
} 
listOfRoundDir = correctList; 
 
if(!toAllRoundTimes){ 
    listOfRoundDir = Array.concat(timeStamp,""); 
} 
//Array.show(listOfRoundDir); 
 
for (j = 0; j <listOfRoundDir.length; j++){ 
    if(listOfRoundDir[j] != ""){ 
        setBatchMode(true); 
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103 
 
105 
 
107 
 
109 
 
111 
 
113 
 
115 
 
117 
 
119 
 
121 
 
123 
 
125 
 
127 
 
129 
 
131 
 
133 
 
135 
 
137 
 
139 
 
141 
 
143 
 
145 
 
147 
 
149 
 
151 
 
153 
 
        stack = 0; 
        for (i = 0; i < listOfNeededDir.length; i++){ 
            showProgress(i+1, listOfNeededDir.length); 
            if(dirBeforeTime == "") 
                dir = dirBeforeCoor + "\\" + listOfNeededDir[i] + "\\" 
+ listOfRoundDir[j] + "\\"; 
            else 
                dir = dirBeforeCoor + "\\" + listOfNeededDir[i] + "\\" 
+ dirBeforeTime + "\\" + listOfRoundDir[j] + "\\"; 
            ch2dir = dir + "Ch2"; 
            ch4dir = dir + "Ch4"; 
//Change the variable of blueDir to the location where file blue.png is 
saved. The file has to be 1000 x 1000 px black image. 
            blueDir = "C:\\pictures"; 
            ch2file = getFileList(ch2dir); 
            ch2file = ch2file[0]; 
            ch4file = getFileList(ch4dir); 
            ch4file = ch4file[0]; 
            blueFile = "blue.png"; 
            open(ch4dir + "\\" + ch4file); 
            open(ch2dir + "\\" + ch2file); 
            open(blueDir + "\\" + blueFile); 
            run("RGB Merge...", "red=["+ch4file+"] green=["+ch2file+"] 
blue=["+blueFile+"]"); 
            index = indexOf(ch4file, "f4"); 
            name = substring(ch4file, 0, index); 
            if (toSave == 1) 
            { 
                File.makeDirectory(dirBeforeCoor + "\\" + magnification 
+ "-RGB\\"); 
                File.makeDirectory(dirBeforeCoor + "\\" + magnification 
+ "-RGB\\" + listOfRoundDir[j] + "\\"); 
                saveAs("png", dirBeforeCoor + "\\" + magnification + "-
RGB\\" + listOfRoundDir[j] + "\\" + name); 
            } 
            width=getWidth; 
            height=getHeight; 
            run("Copy"); 
            close(); 
            if (stack==0) { 
                newImage("RGB Stack", "RGB Black", width, height, lis-
tOfNeededDir.length); 
                stack = getImageID; 
            } 
            selectImage(stack); 
            setSlice(i+1); 
            run("Paste"); 
            setMetadata(name); 
        } 
 
        setSlice(1); 
        run("Select None"); 
        setBatchMode(false); 
        } 
} 
 
 
 97 
APPENDIX 6 (1/2) 
 
FLUORESCENCE IMAGES  
 
 
Fluorescence images of cells cultured on uncoated well (2D), PDMS disc, and PuraMa-
trix® (PM) and gellan gum (GG) hydrogels. Cells were cultured 5 h before staining. Scale 
bar = 200 µm. 
 
 
 
 
 
  
2D PDMS 
PM GG 
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APPENDIX 6 (2/2) 
 
FLUORESCENCE IMAGES  
 
 
Fluorescence images of cells cultures on uncoated well plate (2D) and PDMS disc, and 
encapsulated in PuraMatrix® (PM) and gellan gum (GG) hydrogels. Cells were cultured 
2 d before staining. Scale bar = 200 µm. 
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